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Chapter 1
1.1 What is secondary caries?D ental caries has been described as a chronic and carbohydrate-biofilm-dependent disease which causes demineralization and destruction of dental hard tissues. Tooth demineralization can occur at any location of a dental surface 
when a mature and cariogenic biofilm is present (Selwitz et al., 2007; Takahashi and Nyvad, 2011). When caries develops adjacent to a restoration, the phenomenon is 
defined as secondary caries (Mjor and Toffenetti, 2000; Mjor, 2005).The secondary caries lesion has been described by two locations named as the outer and the cavity wall lesion. The outer lesion develops on the tooth surface next to the restoration margins and the wall lesion forms within the tooth-restoration 
interface (Hals and Nernaes, 1971), see figure 1.
Figure 1. Schematic representation of the two locations of secondary caries lesion (outer and wall lesion).
Primary and secondary caries are not different considering the etiological 
factors involved in it. However, as secondary caries develops around the margins 
of restorations, its formation is influenced by local factors related to the restoration. It makes secondary caries lesion a special pathological entity that deserves its own focus in dental research.A number of clinical and review studies have consistently reported that secondary caries is the main reason for failure of dental restorations (Demarco et al., 
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2012; Opdam et al., 2014; Pallesen and van Dijken, 2015; van de Sande et al., 2016) and that patients with an increased risk for developing caries have their restorations failing mainly due to this problem (Opdam et al., 2014; van de Sande et al., 2013; van 
de Sande et al., 2016). Although there might be some specific diagnostic problems 
for secondary caries such as the difficulty to detect wall lesions, or the question 
whether a defective margin indicates secondary caries (Kidd, 1990), the above-
mentioned findings highlight the importance to investigate the factors involved in secondary caries lesion formation to allow an adequate clinical management of this condition.
1.2 How to study secondary caries
When considering secondary caries as a special pathological entity this affects the ways the condition should be studied. Several caries models are available and each research method has its advantages and limitations.Clinical studies investigating secondary caries could provide high validity 
and the results would be most relevant for daily clinical practice. However, these studies are limited by the need for long follow-up times for caries formation that can be detected clinically, and by the lack of lesion standardization related to a high individual variability (Askar et al., 2017). Unless the tooth is scheduled to be extracted (e.g. orthodontic reasons) and subsequently analysed using destructive methods yielding detailed information on lesion depth and/or mineral loss, secondary caries development must be evaluated by clinical diagnostic methods that are less precise and more likely to be biased. Moreover, for obvious ethical reasons it is not possible to conduct clinical experiments monitoring initial secondary caries lesion development with a focus on identifying etio-pathological factors and 
potential prognostic factors (Jokstad, 2016). Clinical studies may be conducted 
only when there is no risk to the subject or when direct benefit to the subject is 
anticipated (Horowitz, 1976). Therefore, the findings related to secondary caries lesions have been mainly derived from test models (Ferracane, 2017).
The test models vary from highly simplified to more complex ones. The simplest models to study secondary lesions are represented by those using demineralization 
solutions (cycling or static) to create caries at the margins of restorations (Hara 
et al., 2002; Kuper et al., 2013; Peris et al., 2007). These models, however, fail in 
mimicking the biological biofilm necessary for caries lesion development. This 
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may severely limit their simulation of pathological processes and their capability to evaluate preventive measures.
More complex test models using a biofilm to create a cariological challenge have 
been also been used to study secondary caries. In vitro biofilms have been derived from a simple inoculum such as a monoculture, but more complex models using 
consortium biofilms (using a limited number of bacterial species) or microcosm 
biofilms (using unlimited numbers of species, from a relevant clinical source) 
have been reported (Cenci et al., 2009; Khvostenko et al., 2015; Kuper et al., 2015; 
Seemann et al., 2005). Although consortium biofilm models consist of the use of more than one bacterial species, they may be limited because they don’t represent the microbial complexity/interaction that occurs in the oral ecosystem. Microcosms 
originated from saliva or dental plaque may best represent the clinical biofilm. Microcosms are able to maintain much of the complexity and heterogeneity of the original sample enabling oral bacterial community dynamics to be replicated within the laboratory environment and with the possibility of manipulating the variables of interest (McBain, 2009).
In general, various in vitro biofilm models have been described, but many of them have not been completely validated regarding dose-response to antimicrobials 
/ anti-caries agents or reproducibility. This lack of validation makes it difficult to compare among studies and the reliability of data provided by them is therefore uncertain.In situ models represent the next level of clinical simulation and they have been 
also used to study secondary caries (Barata et al., 2012; Hara et al., 2006; Kuper et 
al., 2014; Kuper et al., 2015a; Montagner et al., 2015; van de Sande et al., 2014). In these studies, oral appliances containing dental substrate are worn by volunteers, 
and a natural biofilm is formed over the samples. Usually, subjects enrolled in these studies are instructed to frequently expose the dental substrate to sucrose solution to simulate a highly cariogenic environment. In situ models may serve as a bridge between the natural uncontrolled clinical situation and the highly controlled laboratory situation (Zero, 1995). They also represent an ethical clinical model to study (secondary) caries lesion formation and related factors.
15
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1.3  Which are the factors related to secondary 
caries development?Approximately half of all restorations placed in general dental practice worldwide are a replacement of a failed or defective restoration (Deligeorgi et al., 2001; Gordan et al., 2012; Mjor, 2005). One of the main reasons of restoration failure is secondary caries (Demarco et al., 2012; Opdam et al., 2014). Several factors have been reported to be associated with secondary caries lesion formation, including the marginal defect / gap size, tooth-restoration interface, dentin enzymatic degradation and the overall caries risk. These factors will be discussed in the following sections.
1.3.1 Marginal defect and gap sizeSimilarly to primary caries, the most important aspect to secondary caries is the 
presence of a cariogenic biofilm, but in association with a discontinuity or a gap between the tooth and restorative material (Ferracane, 2017).The presence of a gap at the tooth-material interface can be related to an initial defect in the restoration margin or can develop due to interface degradation during clinical service (Carvalho and Manso, 2016). In either case, the cause of tooth demineralization has been attributed to leakage of bacteria or their acid products into the space /gap formed.For a long time, the microleakage between tooth and restoration was considered as a risk factor for wall lesion initiation and progression. The presence of a microspace would allow bacterial invasion and subsequently lead to caries lesion development (Gonzalez-Cabezas et al., 1995; Gonzalez-Cabezas et al., 1999; 2002). This theory implied that secondary caries could be developed in any gap, but the wider the gap the higher the risk of lesion development (Totiam et al., 2007).Later on, some studies started to show that microleakage was not associated with 
clinical secondary caries (Kidd et al., 1995; Thomas et al., 2007). It was assumed that 
secondary caries wall lesions could not develop without cariogenic biofilm growth 
along the tooth-restoration interface. The width needed for biofilm development 
inside the gap was estimated to be larger than 225 µm (Kidd et al., 1995; Thomas et al., 2007). This new theory was named macroleakage and it is accepted nowadays by cariologists and the majority of operative dentists (Nedeljkovic et al., 2015).Recently, in vitro and in situ studies have been published showing that the width of gap to allow secondary caries wall lesion development may be smaller 
than originally thought by researchers in the field (Khvostenko et al., 2015; Kuper 
1
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et al., 2014; Turkistani et al., 2015). However, the new literature still provides no conclusive answer to the question if there is a relationship between gap size and wall lesion development, and if so, what the threshold is for the gap size needed.Thomas et al. (2007) using a clinical in situ study found that wall lesions could 
develop in gaps ranging from 80 to 225 µm. Kuper et al. (2014) showed that a gap 
size of around 70 μm could enable secondary caries lesions development in a high cariogenic challenge, but a threshold for the wall lesion was not yet established. More 
recently, Khvostenko and collaborators (2015) showed that spaces varying from 
~15-30 µm were able to allow biofilm growth in the tooth-restoration interface. 
If small gaps can allow biofilm formation, it is assumed that wall lesions could be initiated in such space. Thus, considering the above-mentioned, if a threshold for the gap size exists, it could lie within the range of 0-70 µm.
 Although all subjects enrolled in the Kuper et al. (2014) study were exposed to a highly cariogenic protocol which would make all of them high caries risk subjects, not all of them had the same pattern of secondary caries wall lesion development. 
These findings indicate that probably caries lesion progression is influenced by patient factors even in the presence of a standardized and very high cariogenic challenge. This may imply that the minimal gap size for developing secondary caries could also be related to the caries risk of patient.
1.3.2 Tooth-material interfaceWhen a restoration is placed, a new interface is formed between the dental substrate and the restorative material. Ideally, when a good restoration is made and a good sealing is achieved, this protects against the development of secondary caries, at 
least within the interface. However, especially with composite restorations, the quality of interface is negatively affected by physiological conditions of the oral 
environment such as masticatory forces, biofilm, and enzymatic degradation leading to marginal gaps or defects that could predispose to a secondary caries lesion (Carvalho and Manso, 2016).Not only gaps can be related to wall lesion formation, but also other factors, for example, the dental material used (amalgam, composite or adhesive) and the failure 
type of the bonding (Kuper et al., 2015a; Kuper et al., 2015b; Montagner et al., 2015; Montagner et al., 2016a; van de Sande et al., 2014).It is reported that restorative materials can either reduce or increase caries lesion formation in several ways. Dental amalgam, for example, is able to release ions with cariostatic proprieties (Ag, Cu and Zn) decreasing adhesion of bacteria 
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(Glassman and Miller, 1984; Morrier et al., 1998). Moreover, amalgam restorations have the capacity to reduce existing gaps by corrosion products or creep-expansion, thus sealing restoration margins and reducing the risk of the caries formation (Ben-Amar et al., 1995; Osborne, 2006). It has been reported that resin composite 
restorations result in more biofilm accumulation than amalgam and glass ionomer restoration (Svanberg et al., 1990), enhancing bacterial growth due to its surface-topography (Beyth et al., 2008). Despite these observations, there is no conclusive 
evidence for either material in itself promoting or reducing secondary caries (Kuper 
et al., 2015a; Kuper et al., 2015b; van de Sande et al., 2014).Not only the restorative material, but also the adhesive system used to bond the restoration may be involved in secondary caries development. Studies evaluating wall lesion development in restorations with gaps usually did not include the adhesive in their analysis (Diercke et al., 2009; Totiam et al., 2007). Recent studies 
suggested that antimicrobial components in the adhesive may influence caries 
progression (Kuper et al., 2015b; Montagner et al., 2015).Clinically, bonded restorations, usually composite restorations, can suffer mainly 
2 types of interface failures: cohesive and adhesive (figure 2). Cohesive failure occurs when the interface is broken within the adhesive and this adhesive covers both side of interface: both enamel/dentin and composite. Adhesive failure occurs when the adhesive is broken at the interface itself. In this case, adhesive material can be located either on the tooth tissue or on the composite. Depending on this failure type, the failed restoration may present different characteristics and reactions to the secondary caries process.It has been reported that an adhesive failure with the adhesive on the composite 
may favour wall lesion progression, possibly by promoting biofilm growth (Montagner et al., 2015). On the other hand, the presence of adhesive material on the dentin side of the interface was shown to partially protect the dentin against 
demineralization in a simplified test model (Montagner et al., 2016b). However, this 
relationship was not confirmed in an in situ study (Montagner et al., 2015).
1
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Figure 2. Schematic representation of failure types of the composite-tooth interface: ad-hesive and cohesive.
1.3.3 Dentin enzymatic degradationEnzymatic degradation of dentin, promoting dentin adhesive interface failure, may be important in secondary caries formation. Moreover, dentin caries, while mainly characterized by a loss of mineral components similar to enamel caries, has some additional features not shared with enamel, due to its considerable amount of organic material: the collagen matrix. It is assumed that protein degradation plays an important role in dentin caries development, known as the proteolysis theory (Takahashi and Nyvad, 2016; Tjaderhane et al., 2015).Recent studies have suggested that host-derived matrix metalloproteinases (MMPs) and cysteine cathepsins are directly involved in dentin matrix degradation 
during caries formation. MMPs are enzymes, present in dentin, dentinal fluid and saliva which are capable of degrading almost all extracellular matrix components (Visse and Nagase, 2003). Besides dentin caries pathogenesis, MMPs are also claimed to be involved in adhesive hybrid layer degradation of bonded restorations (Mazzoni et al., 2015).MMP activity in the dentin organic matrix can be reduced by endogenous and exogenous inhibitors. Endogenous inhibitors also known as tissue inhibitor of 
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proteinases (TIMPs, TIMP-1 to 4) originate from different human cells exhibiting 
variable and non-specific action against the different MMP members (Chaussain-
Miller et al., 2006). Exogenous inhibitors are artificially synthesized and are available as therapeutic agents (e.g. chlorhexidine, tetracycline, galardin, etc.) (Mazzoni et al., 2015). Most of these inhibitors chelate calcium or replace the zinc ions at the active site and/or interact with the MMP propeptide fragment, while others may prevent MMP access and inhibit activity by coating the substrate (Mazzoni et al., 2012; Mazzoni et al., 2015; Tjaderhane et al., 2013).
The most tested MMP inhibitor is chlorhexidine (CHX) which reduces the activity of MMPs and shows bond strength preservation and reduced interfacial degradation, even at concentrations as low as 0.2% (Breschi et al., 2010; Montagner et al., 2014). MMP inhibitors are also claimed to be effective for dentin caries prevention. (Sulkala et al., 2001; Tjaderhane et al., 2015).
Many studies have investigated the effect of MMP inhibitors (mainly CHX) on 
adhesive bond stability, however there is no literature showing the influence of MMP inhibitors on caries development when the marginal seal is lacking due to defects or gaps at the interface. Considering the potential use of MMP inhibitors for caries prevention and the extensive literature about the use of MMP inhibitor as a technique to prolong bond strength of restoration, the use of MMP inhibitor would also be of interest for secondary caries prevention.
1.4 Aims of this PhD Research
Considering the variability of in vitro biofilm models to study dental caries, the uncertainty of a threshold for small gap sizes and the potential role of MMP inhibitors in secondary caries development, the aims of this PhD research are:
• Systematically review the literature concerning in vitro biofilm models studying dental caries and verifying the reproducibility and dose-response to anti-caries and / or antimicrobial substances (Chapter 2)• Investigate dentin wall lesion development next to resin composite containing very small gaps and evaluate if a threshold for the gap size could be established in vitro (Chapter 3)
1
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• Investigate in situ the dentin wall lesion development next to resin composite containing very small gaps and to evaluate if the threshold gap size is related to the caries risk of the patient (Chapter 4)• Evaluate the effect of using an MMP inhibitor (CHX) in the adhesive procedure on secondary caries lesion progression in vitro (Chapter 5) and in situ (Chapter 6)
21
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Abstract
The aim of this systematic review is to characterize and discuss key methodological aspects of in vitro biofilm models for caries-related research and to verify the reproducibility and dose-response of models considering the response to anti-caries and/or antimicrobial substances. Inclusion criteria were divided into Part I (PI): an in vitro biofilm model that produces a cariogenic biofilm and/or caries-
like lesions and allows pH ﬂuctuations; and Part II (PII): models showing an eﬀect of anti-caries and/or antimicrobial substances. Within PI, 72.9% consisted of 
dynamic biofilm models, while 27.1% consisted of batch models. Within PII, 75.5% corresponded to dynamic models, whereas 24.5% corresponded to batch models. Respectively, 20.4 and 14.3% of the studies reported dose-response validations and 
reproducibility, and 32.7% were classified as having a high risk of bias. Several in 
vitro biofilm models are available for caries-related research; however, most models lack validation by dose-response and reproducibility experiments for each proposed protocol.
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2.1 IntroductionD ental caries is one of the most prevalent oral diseases (Selwitz et al. 2007; Kassebaum et al. 2015) and is related to undisturbed microbial biofilm growth on the surface of the tooth in response to a sucrose-rich diet (Zero et al. 2009).The etiology, diagnosis, treatment, and control of dental caries have been 
extensively studied over the years. The oral cavity is able to inﬂuence the microbial 
diversity and growth of dental biofilms due to a variety of distinct and selective 
environmental conditions such as tooth location, pH, pO2, and type of substratum (Bradshaw and Marsh 1998). Environmental changes, physiological disturbances, 
or selective pressures that might occur during dental biofilm growth are able to 
stimulate the proliferation of certain specific microorganisms that may lead to the 
development of a potential cariogenic biofilm (Parisotto et al. 2010).The physiological complexity associated with the huge microbial diversity of the oral cavity and the ethical issues related to experimentation in clinical studies has 
led to the development of laboratory models in an eﬀort to simulate those clinical 
conditions under well-controlled in vitro conditions (Tang et al. 2003; Keijser et al. 
2008; McBain 2009; Sim et al. 2016). However, the microbial complexity of the oral 
ﬂora and the intricate metabolic/ interactions chains, as well as the incapacity to cultivate some fastidious microorganisms in the laboratory, present some challenges 
to the development of in vitro biofilm models.
Simplified or complex in vitro microbial models have been extensively used 
to produce artificial caries lesions. Artificial biofilms have been cultivated from 
monoculture, defined-multispecies consortia or from complex microbial microcosms using different approaches, such as 24-well plates (Filoche et al. 2007; Ccahuana-Vásquez and Cury 2010; van de Sande et al. 2011; Arthur et al. 2013; Cavalcanti et al. 2014), Petri dishes (Totiam et al. 2007), multiplaque artifcial mouth (MAM) (Sissons 
et al. 1991), constant depth film fermenter (CDFF) (Peters and Wimpenny 1988), 
chemostats (Bradshaw and Marsh 1994), center for disease control (CDC) biofilm 
reactor (Rudney et al. 2012), ﬂow chambers and ﬂow cell (Seemann, Bizhang, et al. 
2005; Seemann et al. 2006; Lynch and Ten Cate 2006b), artificial mouth computer controlled (AMCC) (Mei, Chu, et al. 2013; Mei, Li, et al. 2013), or the multi-station 
continuous-culture biofilm model (MSCBM) (Schwendicke, Doerfer, et al. 2014).
Each of these approaches allows for the control of specific parameters related 
to biofilm growth, such as the time and frequency of exposure to carbohydrates, carbohydrate source, type of substratum, diversity of the microbial inoculum, culture 
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medium, and days of biofilm formation (Tang et al. 2003; McBain 2009). However, it is important to consider the shortcomings of modeling clinical aspects under in vitro conditions. Physical and physiological variables should be incorporated to 
modulate microbial shifts during biofilm development and the cariogenic potential 
of the biofilm; the biofilm must also respond to preventive interventions currently used in clinical practice (Sissons 1997; Sim et al. 2016). Additionally, the strain culture conditions must be standardized to reduce variations in outcomes due to distinct microbial physiological adaptation. Moreover, it has been suggested that 
a good biofilm model should include pH oscillations and microbiological diversity to allow the simulation of oral conditions to develop caries-like lesions or to test antimicrobial treatments (Maltz and Beighton 2012; Buzalaf et al. 2015).
2.2 Materials and methods
Eligibility criteria – Parts I and IIThis systematic review was compiled following the PRISMA statement (Liberati et 
al. 2009). For Part I, evaluating methodological features of in vitro biofilm models, 
the inclusion criteria were defined as follows: the study should (1) use an in vitro 
biofilm model; (2) allow the development of potential cariogenic biofilms and/or 
artificial caries lesions; and (3) allow pH ﬂuctuations (by intermittent sucrose or other carbohydrate exposure in the model). To be included in Part II, evaluation of the ability of the models to test anticariogenic substances, studies should have 
fulfilled the above criteria by testing the eﬀect of anti-caries and/or antimicrobial substances. Only studies published as full-text articles were included in this review. Studies reporting in situ or in vivo investigations, non-microbiological models, 
microbiological models dealing with planktonic cultures, and biofilm models that 
did not present pH oscillations were excluded (Appendix Figure 1 in Supplemental material)
Information sources and search strategyTree databases (PubMed, Scopus, and Isi Web of Science) were used, with a search strategy including controlled vocabulary and free terms around the terms ‘dental 
caries’, ‘dental plaque’, ‘biofilm models’, and ‘in vitro studies’. First, the search strategy was developed for PubMed and then adapted to the other databases (Appendix Table 1 in Supplemental material). References of eligible articles, 
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scientific journals in the field, and narrative reviews on biofilm models were hand-searched to detect other potential studies of interest. The search was limited to language (English, French, German, Portuguese, and Spanish) and not limited to date.
Appendix Figure 1. Search flowchart of articles as described in the PRISMA statement. Part I: in vitro biofilm models that produce a potential cariogenic biofilm and/or artificial caries 
lesion and that allow pH fluctuations. Part II: models showing an effect of anti-caries and/
or antimicrobial substances on caries lesion or biofilm development.
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Appendix Table 1. Search strategy
Search Terms in Pubmed
#5
(((((“In Vitro Techniques”[Mesh] OR in vitro technique OR technique, in vitro OR tech-
niques, in vitro OR in vitro as topic OR in vitro))) AND ((flow cell OR flow cells OR 
continuous model OR batch model OR biofilm model OR biofilm models OR cdff OR 
constant depth film fermenter OR MAM OR multiplaque artificial mouth OR chemostats OR chemostat OR cdc reactors OR cdc reactor OR reactor OR reactors OR biochemical 
reactors OR biochemical reactor OR chemostat system OR artificial mouth OR biore-actor OR bioreactors OR fermentor OR fermentors OR multi-well plate OR multi-well 
plates OR microplates OR microplate))) AND ((“Biofilms”[Mesh] OR biofouling OR bac-terial adhesion OR adhesins, bacterial OR “Dental Plaque”[Mesh] OR plaque, dental OR 
microcosm OR microcosms OR multi-species OR defined-multispecies OR multispecies OR consortium OR “Microbial Consortia”[Mesh] OR consortia, microbial OR microbial consortium OR consortium, microbial))) AND ((“Dental Caries”[Mesh] OR dental decay OR caries, dental OR decay, dental OR carious dentin OR carious dentin OR dentin, carious OR dentin, carious OR dental OR white spot OR white spots, dental OR white spots OR spot, white OR spots, white OR white spot OR dental white spots OR white spot, dental OR “Tooth Demineralization”[Mesh] OR tooth hypomineralization OR hy-pomineralization, tooth OR hypomineralization, tooth OR tooth hypomineralization OR demineralization, tooth OR enamel demineralization OR dentin demineralization OR integrated mineral loss OR mineral loss OR percentage surface hardness change OR caries-affected dentin OR caries-like lesion))Search #1 AND #2 AND #3 AND #4
#4
Search (“Dental Caries”[Mesh] OR dental decay OR caries, dental OR decay, dental OR carious dentin OR carious dentin OR dentin, carious OR dentin, carious OR dental OR white spot OR white spots, dental OR white spots OR spot, white OR spots, white OR white spot OR dental white spots OR white spot, dental OR “Tooth Demineraliza-tion”[Mesh] OR tooth hypomineralization OR hypomineralization, tooth OR hypomin-eralization, tooth OR tooth hypomineralization OR demineralization, tooth OR enamel demineralization OR dentin demineralization OR integrated mineral loss OR mineral loss OR percentage surface hardness change OR caries-affected dentin OR caries-like lesion)
#3 Search (“Biofilms”[Mesh] OR biofouling OR bacterial adhesion OR adhesins, bacte-rial OR “Dental Plaque”[Mesh] OR plaque, dental OR microcosm OR microcosms OR multi-species OR defined-multispecies OR multispecies OR consortium OR “Microbial Consortia”[Mesh] OR consortia, microbial OR microbial consortium OR consortium, microbial)
#2
Search (flow cell OR flow cells OR continuous model OR batch model OR biofilm model 
OR biofilm models OR cdff OR constant depth film fermenter OR MAM OR multiplaque 
artificial mouth OR chemostats OR chemostat OR cdc reactors OR cdc reactor OR reac-tor OR reactors OR biochemical reactors OR biochemical reactor OR chemostat system 
OR artificial mouth OR bioreactor OR bioreactors OR fermentor OR fermentors OR multi-well plate OR multi-well plates OR microplates OR microplate)#1 Search (“In Vitro Techniques”[Mesh] OR in vitro technique OR technique, in vitro OR techniques, in vitro OR in vitro as topic OR in vitro)
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Screening and study selection
All retrieved references were managed and stored in EndNote X7® software 
(Thomson Reuters, San Francisco, CA, USA). Duplicates were identified and excluded. 
Two independent examiners (TTM and FHV) assessed all identified studies in the electronic search of the abovementioned databases. No blinding was carried out regarding author names and journals. After title screening, the abstracts of the 
studies were carefully evaluated. All eligible studies were identified, and the full text was read. In the case of doubt during abstract evaluation, the full text of the article was also read. In the case of disagreement, a third reviewer (MSC) was consulted, and the decision was made by consensus. During the process of selection, studies were included or excluded using pilot-tested tables addressing the following: (1) 
microbiological model (yes or no); (2) development of cariogenic biofilms and/or 
artificial caries lesions (yes or no); (3) pH oscillation by carbohydrate (yes or no); and (4) evaluation of anticariogenic and/or antimicrobial substances (yes or no).
Data collection and risk of bias assessmentFor Part I, the following data were extracted from all selected articles: apparatus 
used to allow biofilm growth; surface coating method; inoculum source; substratum 
for biofilm growth; length of the experiment; culture medium and ﬂow rate; 
carbohydrate source; and time-frequency of exposure of biofilms to carbohydrates. For Part II, the collected data involved the evaluation methods, anticariogenic/antimicrobial substances used, dose-response and reproducibility of the model, and 
significance of the eﬀect within the response variables. Two reviewers extracted all the data simultaneously under a standardized outline for both Part I and II. A brief 
description of each biofilm model was carried out, and the models were divided 
according to the presence or absence of the ﬂow-rate of a culture medium (batch 
or dynamic biofilm models).The quality of the studies included in Part II was assessed using the criteria of 
Sarkis-Onofre et al. (2014) with modifications. The following parameters were used for risk of bias assessment: description of the sample size calculation, randomization of treatment allocation, presence of a control group, blinding, standardization of samples (teeth or other surfaces), and control of contamination (sterilization before starting the experiment). If the authors reported the parameters listed above, the 
article received ‘Y’ (yes); if the information was not found, the article received ‘N’ 
(no). The articles that obtained ‘Y’ for one to two items were considered to have a 
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high risk of bias, those with three to four were considered to have a medium risk of 
bias, and those with five to six were considered to have a low risk of bias.
2.3 Results and discussion
Study selectionThe search retrieved 1,335 records, and after the removal of duplicates, 1,115 titles were screened. The appraisal of titles and abstracts resulted in the selection 
and assessment of 209 articles for eligibility. Eighty-five studies met the inclusion 
criteria for Part I, and 49 of the selected studies evaluated the eﬀect of antimicrobial and/or anticariogenic substances and, therefore, were selected for the Part II analysis (Appendix Figure 1 in Supplemental material). The reasons for exclusion of articles included the following: not being a microbial model for dental caries (n 
= 8), not presenting pH oscillation by carbohydrate (n = 115), and the inability to retrieve the full-text article after attempting to contact the authors twice (n = 1).
Methodological features – Part INarrative reviews on the historical and general characteristics of microbial models are well documented in the literature (Sissons 1997; Tang et al. 2003; McBain 2009; Salli and Ouwehand 2015; Sim et al. 2016); however, detailed information on the 
experimental conditions for biofilm growth have not been addressed in previous reviews.
Several studies focusing on dental caries biofilm models were excluded from this systematic review because they did not satisfy the proposed inclusion criteria (allow 
pH ﬂuctuations by intermittent sucrose or other carbohydrate exposure). Although 
they have contributed significantly to the understanding of dental caries as part of a complex and dynamic process (Exterkate et al. 2010; Guggenheim et al. 2001), the 
present review only reported those biofilm models that applied pH shifts during 
biofilm growth, since they may simulate more appropriately a clinical condition for 
caries development. The focus on this systematic review was not to revise all biofilm models available to study dental caries but to show in detail those dental caries 
biofilm models with similar characteristics. Therefore, this is the first review to describe and discuss the methodological parameters related to the different in vitro 
biofilm models for the development of artificial caries lesion with characteristics closer to clinical conditions.
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Descriptive data of the methodological features for each included study are presented in Appendix Table 2 in Supplemental material, and a comparative discussion of each element is presented under the sub-topics below.
Batch and dynamic biofilm modelsFor this systematic review, the models were divided according to the presence or 
absence of any kind of ﬂow during biofilm growth (dynamic and batch models, 
respectively). A brief description of the biofilm models is shown in Table 1, and positive and negative points of dynamic and batch models are summarized in Appendix Table 3 in Supplemental material.
Both categories of models were found to produce potential cariogenic biofilms 
and/or artificial caries lesions (Appendix Table 2 in Supplemental material). Within 
the studies reporting dynamic models, 37.10% used a ﬂow chamber/cell, 25.81% used MAM, 16.13% used CDFF, 9.68% used chemostats, 4.84% used MSCBM, and 
3.22% used AMCC and CDC biofilm reactors. In the batch model approaches, 91.3% were carried out in 24-well plates and 8.7% in Petri dishes.In the dynamic models, the output is controlled by peristaltic pumps, which 
provide a precise ﬂow of medium or carbohydrate to the system according to the 
study protocol. In general, models simulate the salivary ﬂow rates, which vary 
from 0.04 to 2.5 ml min−1 (mimicking an unstimulated or a stimulated condition), 
whereas some systems, such as ﬂow cells or chambers, presented higher ﬂow-rates 
(60 ml min−1). Possible changes in methodological parameters make dynamic 
in vitro models adaptable and ﬂexible to simulate the complexity of the oral 
environment. However, the majority of these models do not provide independent 
biofilm growth and require more than one experimental run, making them costly and time-consuming.
In the CDFF model, biofilms are grown in a set of 15 pans, but the samples are 
not grown in an independent manner. Modifications of this approach (by rotating 180° back and forward) allows the use of that model in a reciprocal mode in two simultaneous growth conditions (representing two treatment modes) (Deng et al. 
2005; Zaura et al. 2011), yet within only one CDFF run. In general, the ﬂow cell/
chambers also have this limitation. In each cell or chamber, the biofilms formed are dependent on the same growth condition and either multiple runs or multiple 
chambers are needed to produce independent biofilms.New settings providing independent units for the simultaneous accommodation 
of experimental samples and/or biofilm formation seem to be desirable to overcome 
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this limitation (Maske et al. 2016). Model approaches such as MAM, MSCBM, and 
AMCC also allow independent biofilm development but the complex assembly of these models also seems to be a limitation to their use. Considering the capability of reproducing clinical oral conditions, multi-well plates, as batch culture-based 
models, seem to be less eﬀective as dynamic models in mimicking clinical conditions in a laboratorial environment (Salli and Ouwehand 2015). In these models, bacterial growth occurs in the presence of a limited availability of nutrients. Under this condition, the bacterial growth is faster than in the oral cavity, representing an unusual behaviour in nature (McBain 2009). Tis phenomenon may explain why experiments based on batch culture are on average of a shorter duration than those in more complex models.
Culture medium
Eleven diﬀerent types of artificial saliva solutions and eight culture media are 
reported in this review (Appendix Table 2 in Supplemental material). Artificial saliva (AS) compositions are presented in Appendix Table 4 in Supplemental material.The choice of the proper culture medium seems to depend more on the complexity of the inoculum rather than the complexity of the model. Deng et al. (2004) and Deng 
and Ten Cate (2004) used a simplified medium (BHI) for biofilm growth in a CDFF approach using a pure suspension of S. mutans as a microbial source, while van de 
Sande et al. (2011) used the most complex artificial saliva medium (defined medium mucin, DMM) (Wong and Sissions 2001) in a 24-well plate model using saliva as an 
inoculum for biofilm growth.
In general, the nutritional needs of biofilm cultivated from the monoculture of 
pure microorganisms allows for the use of a simplified culture medium based on tryptone, peptone, yeast extract, casein, and a source of dextrose, such as a TSB(S), 
BHI, and UTEYEB medium (Deng et al. 2005; Seemann et al. 2006; Fernández et 
al. 2016). However, the complexity of biofilms grown from microbial consortium or a microcosm requires a more enriched culture medium in which the chemical composition tends to be similar to natural saliva (Wong and Sissions 2001).
Artificial saliva media (Appendix Table 4 in Supplemental material) are based on a low carbohydrate solution that contain proteins, electrolytes, amino acids, and 
supplements other than the low-molecular-weight compounds found in simplified 
media, supporting the growth of microorganisms with different and specific 
nutritional needs. Wong and Sissons (2001) compared an undefined chemical 
culture medium (BMM) to a chemically defined analogue to saliva (DMM) to 
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grow microcosm biofilms. They found that the medium with more similarity to 
natural saliva allowed more realistic biofilm growth rates and the investigation of nutritional variables on plaque. Moreover, the reduced carbohydrate availability on AS medium stimulated synergistic and antagonistic metabolic interactions among microorganisms such as those found in the oral cavity (Elias and Banin 2012).
In addition to artificial saliva and simplified culture media, some studies have also described the use of fresh processed saliva as a method to cultivate dental 
biofilm (van der Ploeg and Guggenheim 2004; Thurnheer et al. 2006; Giertsen et al. 2011). In this method, whole saliva is processed by centrifugation and pasteurization methods (Guggenheim et al. 2001) and is used to reproduce fastidious periods of plaque development. Although shorter experimental times (~64 h) have been reported, a very large amount of saliva must be collected to conduct the experiment, 
and thus the protocol is difficult to perform.
Inoculum sourceWhile the choice of a culture medium seems to depend on the type of inoculum, the selection of an inoculum source depends on the needs of the study or on the research question to be addressed. Monocultures are better indicated for studies aiming 
to evaluate specific physiological aspects of the biofilm through the response of 
the test inoculum to some specific experimental conditions. Streptococcus mutans 
has been the microorganism of choice for monoculture biofilms (Zanin et al. 2005; 
Totiam et al. 2007; Diercke et al. 2009; Fernández et al. 2016). Defined microbial consortia-based models, however, may be chosen to study ecological changes that 
would otherwise be difficult to measure for reasons of complexity in a more diverse microbial community (McBain 2009).The studies included in this review have reported microbial consortia from two 
to 10 species for cariogenic biofilm development (Bradshaw et al. 2002; Yip et al. 
2007; Mei, Li, et al. 2013; Schwendicke, Horb, et al. 2014; Fernández et al. 2015). 
This model may pose an advantage over monoculture models since the biofilm is grown as a result of the interaction among different microorganisms and not only 
as a result of the role of a specific strain. Additionally, since the proportions and types of microorganisms are adjusted at the start of the experiment, it is possible to monitor the effect of treatments or conditions on the competition or synergism 
among the players in the consortium. However, the disadvantage is related to its 
poor representativeness in comparison to natural biofilms.
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Microcosm-based models seem to more closely mimic the natural dental biofilm (McBain 2009). By using saliva or dental plaque as an inoculum, thousands of different strains may compete among each other to establish a microbial community (Angker et al. 2011; Mei, Chu, et al. 2013; Li et al. 2014; Maske et al. 2016; Signori et al. 2016).Dental caries is then a result of metabolic interactions of such diverse 
communities. However, it is important to point out that an oral cavity is composed of more than 700 species (Dewhirst et al. 2010), and some of these species can be lost 
when in vitro microcosm biofilm models are used to mimic the oral environment. 
This limitation may be inherent to laboratory biofilm models and can be explained by the use of anaerobic conditions other than those found in the oral cavity and 
also by a diﬀerent composition of growth medium in comparison to natural saliva (Rudney et al. 2012).The frequency in which saliva is inoculated varies among experimental models (Cutress et al. 1995; Sissons et al. 1995, 1998; Wong and Sissions 2001; van de Sande et al. 2011). Wong and Sissons (2001) compared the frequency of inoculation procedure, viz. one and three times, in the MAM apparatus, and there were no 
differences regarding biofilm patterns of growth. However, this procedure was not 
tested in other biofilm approaches.
When biofilms originate from different types of inocula (dental plaque or saliva), from caries-active and caries-free individuals, the cariogenic potential of these 
microcosm biofilms seems to be similar (demineralization and selection of acid-tolerant bacteria) regardless of the differences present in the baseline source of microorganisms (Azevedo et al. 2011, 2014; Signori et al. 2016). This is usually 
explained by the observation that these in vitro biofilms respond more to ecological pressures from the environment rather than the source or type of inoculum (Signori et al. 2016). Although caries lesion formation may respond similarly according to 
ecological pressures, Rudney et al. (2012) demonstrated that microcosm biofilms derived from saliva or dental plaque seems to be relatively stable within the subject over time, but there are clearly differences in the species composition between 
subjects. Even with some species in common, each biofilm derived from a microcosm seems to be unique in microbial composition and with individual characteristics, which should be considered in models using microcosms.
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Surface coating
The biofilm formation on the tooth surface involves three main steps: (1) formation 
of the conditioning film, (2) cell-to-surface attachment of the primary colonizer, and (3) cell-to-cell interaction between late and new colonizers (Davey and O’Toole 
2000). The first step in oral biofilm formation is represented by the adsorption of salivary molecules such as proteins, carbohydrates and lipids to the tooth (Lindh 
et al. 2014). The acquired pellicle formation serves as a substratum for the first 
bacteria (primary colonizers) and thus plays a crucial role in biofilm initiation (Marsh 2006).Considering the studies included in Part I, > 55% of bacteria used natural saliva (processed or not) as a source for acquired pellicle formation, and 7.1% of the studies 
used artificial saliva to produce the coated surface. However, in most of the other studies, the methods employed to produce a coated substratum or the sources were not clear or not mentioned.In general, when microcosm models were used, saliva was the simultaneous source for the acquired pellicle and inoculum (Cenci et al. 2009; van de Sande et al. 
2011; Maske et al. 2016). However, in the MAM device, the surface coating method and inoculum process were performed in independent steps (Sissons et al. 1991). 
Some ﬂow cell/chamber approaches reported that the inoculum (by consortium or monoculture) was maintained in contact with the substratum for up to 4 h to allow bacterial adhesion (Zampatti et al. 1994; Fontana et al. 1996, 2000, 2002; Thneibat et al. 2008). In this case, the inoculum and salivary pellicle formation seem to have been performed concomitantly. The bacteria per se could have secreted some products/molecules that served as the substratum coating method (Busscher and van der Mei 2000). In contrast, most of the microplate models used saliva for 
substratum coating (HA or tooth material) when consortia or monoculture was the chosen inoculum (van der Ploeg and Guggenheim 2004; CcahuanaVásquez and Cury 2010).
The findings from this review indicate that several surface coating methods 
were used for several available biofilm model approaches. These methods were neither the same for each kind of inoculum nor for each kind of protocol used to 
support biofilm growth (source of carbohydrate and culture medium). This fosters 
the diversity of biofilm caries modeling and highlights the need to validate these methods. The impact of these different methods on surface coating of carious lesion outcomes remains unclear.
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Time and frequency of exposure to dietary carbohydratesA cariogenic diet is an indispensable factor for the development of cariogenic 
biofilms and caries lesion formation. The effect of carbohydrate intake has been shown to be selective and demonstrates microbiological shifts in the presence of a 
low pH (Marsh 2006).
To reproduce the pH oscillation commonly found in the oral cavity, dynamic models deliver carbohydrates in small volumes and at high dilution rates. Under this condition, it is possible to maintain a degree of control over the cariogenic challenge 
provided to the biofilm (Hodgson et al. 2001). The time and frequency of exposure 
are controlled by peristaltic pumps that provide a precise ﬂow of carbohydrates to the system according to the study protocol.In the CDDF models, the frequency and time of exposure varied between three to eight times daily, for 5–30 min (Pratten and Wilson 1999; Seemann, Bizhang, et al. 2005; Deng et al. 2004; Cenci et al. 2009; Zaura et al. 2011).
The artificial mouths described by Mei, Chu, et al. (2013) and Sissons et al. (1991), and the subsequent publications using these approaches, showed that the frequency of sucrose exposure varied from three to 12 times daily, with exposure 
for 6 min in each pulse. For the ﬂow chamber and ﬂow cell models, several exposure 
protocols were also reported, varying from two (Hodgson et al. 2001; Lynch and 
Ten Cate 2006b; Xie et al. 2008) to > 12 times daily (Seemann, Bizhang, et al. 2005; 
Seemann, Klück, et al. 2005; Seemann et al. 2006; Diercke et al. 2009); and from 1 
min (Lynch and Ten Cate 2006b; Xie et al. 2008) to 1 h (Perrons and Donoghue 1990; Donoghue and Perrons 1991). For the chemostat models included in the present review, carbohydrate was delivered from one to four times daily, whereas in the 
CDC reactor, exposure occurred five times a day for 1 min (Rudney et al. 2012; Li et al. 2014).
In batch models, pH oscillations are reproduced with an intermittent regimen of culture media (containing a source of sugar or no source). Microplate models report the use of several intermittent sucrose regimens varying in concentration and time 
of exposure. In microcosm biofilm models, sucrose was applied once in protocols with exposure for 4 or 6 h, while the sugar was applied more times per day (three to eight times daily) and with different exposure times (from 1 to 45 min) in those studies using consortia or monoculture.Since the delivery of carbohydrate is manually performed by researchers (batch models) or mechanically by pumps (dynamic models), the frequency and exposure times can be easily altered. If and how this difference in frequency and exposure 
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times affects the biofilm or the formation of artificial caries have not yet been fully 
examined in complex biofilm models, but a dose-response effect of frequency, time and the concentration of carbohydrate should be validated (for several parameters) against in situ studies showing the ability to more accurately reproduce the clinical situation.Even under distinct regimens of exposure to dietary carbohydrates, all studies included in the present review showed a direct relationship between a cariogenic 
diet and caries lesion or cariogenic biofilm development as a response to pH oscillations produced by sugar pulsing. These models are able to mimic the natural 
pH curves observed in plaque in vivo, one at low sugar availability (pH rise) and 
the other at high sugar availability (no pH rise). In this sense, the presence of pH oscillations makes the model more representative of caries lesion development once it reproduces the phenomena of de- and re-mineralization/rest periods and may 
be better suited to produce artificial caries-like lesions. Beyond representing the in vivo phases of dental plaque and allowing microbial shifting, in vitro models 
with pH oscillation avoid erosion of the tooth surface. A previous study for the 
development of an in vitro cariogenic biofilm model (van de Sande et al. 2011) showed that, under a continuous sucrose exposure regimen (0.5% sucrose), erosion occurred on the tooth surfaces, probably due to continuous exposure to acidogenic 
activity of the cariogenic biofilm. Thus, short-term in vitro studies examining initial 
microorganism interactions or metabolic activity (minutes or hours) may benefit 
from a continuous low pH, but an intermittent regimen seems appropriate for 
artificial caries lesion formation.Most of the studies included in this review used sucrose as a nutrient source, and monosaccharide pulsing was only used by seven studies (Bradshaw et al. 1989, 1996, 2002; Perrons and Donoghue 1990; Giertsen et al. 2011). Although monosaccharides are potentially cariogenic (Cury et al. 2000), sucrose is especially able to provide energy for extracellular polysaccharide production that favors cariogenic plaque formation (Leme et al. 2006). Thus, sucrose pulsing seems to be more representative 
of in vivo biofilms and may be preferred for dental caries related studies.
Substratum for biofilm growth
Several substrata have been used for in vitro biofilm growth (Appendix Table 2 in 
Supplemental material). Human and bovine teeth (enamel, dentin, and root dentin) are generally used to study caries lesion development whereas inert materials (glass and plastic) or hydroxyapatite disks have been used mainly to study microbial 
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changes during biofilm development or in response to antimicrobial agents. 
Additionally, surfaces with specific designs such as grooves within dentin (Deng and Ten Cate 2004; Deng et al. 2004, 2005), with standardized gaps between the 
restoration and dental substratum (Cenci et al. 2009; Diercke et al. 2009; Kuper et 
al. 2015), and sealed fissures from natural teeth have also been reported (Seemann, 
Bizhang, et al. 2005; Seemann, Klück, et al. 2005). Dental materials and dental tissues have been used to investigate secondary caries development (Fontana et al. 2002; Seemann, Bizhang, et al. 2005; Cenci et al. 2009; Diercke et al. 2009; 
Kuper et al. 2015) or bonding to the caries affected dentin substratum (Maske et al. 2015; Peixoto et al. 2015). Thus, depending on the research question, a more 
representative surface may be used. However, the type of substratum may affect 
biofilm development and even the caries output, as previously demonstrated (Zaura et al. 2002; Lynch and Ten Cate 2006a). This phenomenon may be explained by the selective adherence of microorganisms to each surface or by the buffering of the environment caused by tooth substratum demineralization, especially dentin (Lynch and Ten Cate 2006a).
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0.7 ml 
min-1  T
SBS (5
% sucr
ose), 3
x, 
30 min
(Fonta
na et a
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 C
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I m
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° C
Saliva
Bovine
 dentin
e
21
DMM s
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 d
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° C
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tium
(6 spec
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H
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64h
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rocess
ed
Saliva
mFUM
 with 0
.30%
glucos
e + 0.3
0% suc
rose, 4
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5x
(Gierts
en et a
l., 2011
)P
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ized sa
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room t
emper
ature
Consor
tium
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64h
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Saliva
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 + 0.30
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e, 45 m
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anti et
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 f
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d
, 3
0 
m
in
, 
37° C
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c
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ndez e
t al., 20
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ed
, 3
0 
m
in
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37° C
Consor
tium
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Ename
l bovin
e
4
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T
E
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E
B
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ta
ti
c
10% su
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8x, 3 m
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(Vanni
 et al., 2
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saliva,
 4h, roo
m tem-
peratu
re, sha
king
Saliva 
+ cons
ortium
(6 spec
ies)
H
A
64.5h
Fresh p
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 f
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 f
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m
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Chapter 2
 Appendix Table 3. Batch and dynamic models: positive and negative points
Batch models Dynamic models
Po
si
ti
ve
 p
oi
nt
s · Shorter experiments· Simple equipment· Easy manipulation· Low-cost· Multiple conditions can be tested simultaneously
· Longer experiments· Salivary flow, shear-stress and Stephan curves can be easily repro-duced.· Environment closely reproducing in 
vivo conditions
N
eg
at
iv
e 
po
in
ts · Lack of flow-rate and shear-stress simulation · High-cost and time-consuming models· Complex equipment and manipulation· Generally only one condition can be tested in each experimental run
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Appendix Table 4. Artificial saliva solution composition of the reported studies
Saliva Type Artificial saliva composition
AS1 Lab-lemco 1 g l-1, yeast extract 2 g l -1, proteose peptone 5 g l-1, type III hog gastric mucin 2.5 g l-1, sodium chloride 0.2 g l-1, potassium chloride 0.2 g l-1, calcium chlo-
ride 0.3 g l-1; 1,25 ml l-1 of a 0.2 mm filter sterilized solution of 40% urea.
AS2 (g l-1): Mucin (type II; porcine; gastric), 2.5; bacteriological peptone, 2.0; tryptone, 
2.0; yeast extract, 1.0; NaCl, 0.35; KCl, 0.2; CaCl, 0.2; cysteine hydrochloride, 0.1; 
hemin, 0.001; and vitamin K1, 0.0002.
AS3 (mg l-1) 233 ammonium chloride, 210 calcium chloride dihydrate, 43 magnesium chloride, hexahydrate, 1162 potassium chloride, 354 potassium di-hydrogen ortho-phosphate, 222 potassium thiocyanate, 13 sodium citrate, 535 sodium hydrogen carbonate, 375 di-sodium hydrogen orthophosphate, 2500 glycoprotein, 25 albu-min, 173 urea, 10.5 uric acid, 0.1 creatinine, 13 choline, 41 mixture of amino acids, 
0.8 mixture of vitamins, 3.105 alpha amylase 3.105 somogyi units/ litre (pH 6.8).
AS4 2.5 g l-1hog gastric mucin Type III, 2 g l-1proteose peptone, 1 g l-1 trypticase pep-
tone, 1 g l-1 yeast extract, 0.5 g l-1 glucose, 2.5 g l-1 KCl, 0.1 g l-1 cysteine–HCl and 
1mg l-1 haemin (pH 7.4).
AS5 0.33 g l-1 KH2PO4, 0.34 g l-1 Na2HPO4, 1.27 g l-1 KCl, 0.16 g l-1 NaSCN, 0.58 g l-1 
NaCl, 0.17 g l-1 CaCl2.2.H2O, 0.16 g l-1 NH4Cl, 0.2 g l-1 urea, 0.03 g l-1 glucose, 0.002 g l-1 vitamin C and 2.7 g l-1 mucin.
AS6 (in mmol l-1): 10.2 NaCl, 10.7 KCl, 0.29 KH2PO4, 4.59 K2HPO4, 2.38 NAHC03, 0.25g Bio-Trypticase, 0.25g yeast extract.
 AS7 Na2S= 0.0008g; Mg2P2O7= 0.0008g; Mucin= 2.0000g; CO(NH2)2= 0.5000g; 
Na2HPO4= 0 .3000g; CaCl2= 0.3000g; KCI= 0.2000g; NaCl= 0.2000g and 500 ml of 
distilled H2O.
CDM (in g l-1): (NH4)2SO4 (0.8); NaCl (0.6); ascorbic acid (0.5); MgCl2.6H2O (0.16); Ca-
Cl2.2H2O (0.01); cysteine hydrochloride (0.3). 20 ml l-1 of a vitamin mix (g l-1): 
biotin (0.002); folic acid (0.002); pyridoxine hydrochloride (0.01); riboflavin (0.005); thiamine (0.005); nicotinic acid (0.005); pantothenic acid (0.005); vitamin B-12 (0.0001); p-aminobenzoic acid (0.005); thioctic acid (0.005). 13C-labeled glucose and 13C-L-lactate. Glucose (2.5 g l-1) and lactate (1.5 g l-1).
DMM Salts (mmol l-1): CaCl2 1.0, MgCl2 0.2, KH2PO4 3.5, K2HPO4 1.5, NaCl 10.0, KCl 15.0, 
NH4Cl 2.0, Urea 1.0, Mucin (g l-1) 2.5, 5 g l-1 casein. Basal salivary amino acids (µmol l-1): Alanine 50, Arginine 50, Asparagine 25, Aspartic acid 25, Cysteine 50, Glutamic 
acid 25, Glutamine 25, Glycine 100, Histidine 10, Isoleucine 25,Leucine 25, Lysine 50, Methionine 10, Phenylalanine 25, Proline 100, Serine 25, Taurine 75, Threonine 25, Tryptophan 10, Tyrosine 15, Valine 25. Vitamins and growth factors (µmol l-1): 
Choline chloride 100, Citrate 50, Uric acid 50, Haemin 10, Inositol 10, Ascorbic acid 5, Menadione 5, Niacin 5 0.24, Pyridoxine 4, Creatinine 1, p-Aminobenzoic acid 1, 
Pantothenic acid 1, Thiamine 1, Riboflavin 0.3, Biotin 0.1, Cyanocobalamin 0.05, Folic acid 0.025.
MW (mg l-1): KCl 624.6, NaCl 866.6, K2HPO4 33.8, MgCl2 59.6, CaCl2.2H2O 166.6.
MS 0.33g KH2PO4, 0.34g Na2HPO4, 1.27g KCl, 0.16g NaSCN, 0.58g NaCl, 0.17g CaCl2.2H2O, 
0.16 g NH4Cl, 0.2 g urea, 0.03 g glucose, 0.002 g vitamin C and 2.7 g mucin and 1000 
ml of distilled H2O (pH 6.8).
Note: Artificial saliva described according to paper citation. For references see appendix table 1.
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Biofilm models and anticariogenic/ antimicrobial substances – Part IIDescriptive information about the 49 selected papers showing outcomes and bias risk is shown in Table 2. A discussion of the evaluation methods and response variables as well as the risk of bias assessment are presented in the sub-topics below.
Dose-response and reproducibility
Thirty of the 49 studies reported artificial caries lesion formation and most of them 
used dynamic biofilm models (76.7%) to investigate the effect of anticariogenic/antimicrobial substances. A dose-response evaluation was only reported in 10 
studies. MAM was evaluated for ﬂuoride concentration (0, 0.5, 1, 2, 5, 100, 3,000, 
and 5,000 ppm), demonstrating a dose-response effect on both pH and de and re-mineralization (Cutress et al. 1995; Angker et al. 2011) and ethanol was evaluated at 
different concentrations (10, 20, 30, 40%), altering the pH and the microbiota formed under those different conditions (Sissons et al. 1996). Angker et al. (2011) used the model to produce human enamel caries-like lesions from microcosms cultivated for 
28 days with DMM and with pH oscillations performed by the application of 10% 
sucrose five times daily. Cutress et al. (1995) produced bovine enamel artificial caries lesions using microcosms cultivated by BMM and with sucrose application 
four times daily (10 or 5%). Sissons et al. (1996) described the biofilm dose-response to ethanol using a protocol that also used BMM but with 5% sucrose applied only three times per day.
For the ﬂow cell/chamber approaches, Lynch and Ten Cate (2006b) demonstrated 
dose-response effects on the pH, mineral, and microbial contents of calcium glycerophosphate at different concentrations (CaGP 0.10, 0.25, 0.50%). In this study, 
human enamel and dentin caries-like lesions were produced by a biofilm consortium cultivated in a mix of MV and TSB+5% sucrose applied 3× daily. A dose-response validation was also described by Maske et al. (2016) for chlorhexidine (0, 0.03, 0.06, and 0.12%). The protocol used in this chamber approach showed that bovine enamel 
artificial caries was responsive to a CHX solution when microcosm biofilms were 
grown for seven days by delivery of 0.06 ml min−1 of DMM associated exposure to 5% sucrose (three times per day).Chlorhexidine (0.012, 0.024, 0.03, 0.06, and 0.12%) was also used to validate 
microplate models considering pH, mineral (van de Sande et al. 2011), and microbiological variables as outcomes (Ccahuana-Vásquez and Cury 2010). A microplate microcosm model was developed by van de Sande et al. (2011), and 
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the dose-response to CHX was determined by biofilm growth in bovine enamel. In this study, DMM was used in association with 1% sucrose and applied 1× per 
day. A monoculture microplate model was CHX-dose-validated by Ccahuana-
Vásquez and Cury (2010). The authors used UTEYEB associated with 10% sucrose 
applied 8× daily to produce a bioflm by S. mutans in the bovine enamel substrate. Using a similar monoculture model approach, Ribeiro et al. (2012) showed a dose-
response to iron (1.0, 10.0, and 100.0 μg Fe m−1) on mineral loss. In contrast to the previous model, these authors used 8% sucrose applied 8× per day for 2.5 min instead of 1 min. Fernández et al. (2016) and Giacaman et al. (2015) showed, 
respectively, a dose response to ﬂuoride (0, 150, 450, and 1,350 ppmF, on bovine enamel) and fatty acid (0.1, 1, and 10 mM, on bovine enamel and dentin root). Both 
studies used a monoculture microplate bioflm model (S. mutans), however, with a different protocol for the 10% sucrose solution application. In a study conducted by Fernández et al. (2016), sucrose was applied eight times daily (3 min), whereas 
Giacaman and collaborators applied sucrose only three times per day. Biofilms were formatted in a bovine substrate (enamel and root dentin).
For validation without a dose-response effect, chlorhexidine (CHX) and 
ﬂuoride were most frequently used (51.2%). Although not used at the same 
concentration, CHX generally showed a significant effect on the demineralization and microbiological outcomes in different models (dynamic and batch). Even with 
different methodological protocols to producing biofilms, the models were CHX-
responsive and therefore closer to clinical reality. However, CHX was not responsive to the microbiological outcome when used as varnish at a 1% concentration. Thneibat et al. (2008) explained this phenomenon based on the experimental time (long) and the use of one application of the product. Fluoride was used in different application methods and also showed a response to outcomes evaluated mainly in 
demineralization. These findings can also be related to expected ﬂuoride clinical use and therefore also represent a model that is more similar to clinical conditions.Ideally, every proposed model should provide a (reproducible) dose-response pattern for both anti-caries and antimicrobial substances; this would be particularly important for studies lacking positive and negative controls (Sissons et al. 1991; Shu et al. 2000; McBain et al. 2003b; Fontana et al. 2004; Deng et al. 2005) because it would demonstrate the sensitivity of the model regardless of the effect of the investigated substance.
Of the 49 selected studies, only seven studies reported reproducibility. However, 
reproducibility to dose-response, with respect to CHX, was only shown by van 
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de Sande et al. (2011). Using MAM, Sissons et al. (1991, 1995) demonstrated 
reproducibility to plaque growth, PO4 levels, and pH readings. CDFF and other 
chamber/cell ﬂow approaches also demonstrated reproducibility to an established protocol (Fontana et al. 2000; Deng et al. 2005; Seemann et al. 2006; Maske et al. 2016). For the remaining studies included in Part II, no reports were found to be reproducible.
However, in this review, reproducibility was only evaluated for the studies included in Part II, but the studies selected for Part I (without tests with standardized antimicrobial or anti-caries substances) also reported plaque growth reproducibility 
(Hodgson et al. 2001; McBain et al. 2003c; Deng and Ten Cate 2004; Rudney et 
al. 2012; Edlund et al. 2013), pH readings (Sissons et al. 1992), and mineral loss 
(Bradshaw et al. 1996; Fontana et al. 1996). These findings indicate that a biofilm model and its respective protocol, despite lacking a tested anti-caries pattern, is able 
to develop similar caries lesions and cariogenic biofilms in independent experiments under the same protocol of sucrose exposure and nutrient medium.
Evaluation methods and response variablesA wide variety of evaluation methods were used in the included studies. Some of 
these focused on the microbiological composition of the biofilm (microbiological counts, quantitative polymerase chain reaction (PCR), and denaturing gradient gel electrophoresis (DDGE)), while others were designed to evaluate the chemical 
and physical biofilm structure (biofilm weight, insoluble and soluble extracellular polysaccharide analysis, confocal laser scanning microscopy, polarized light 
microscopy, Fourier transform infra-red spectroscopy, ﬂuorescent microscopy, backscattered electron imaging-scanning electron microscopy, and chemical 
analysis of F, Ca, and P ions) and its acidogenic capacity (pH, organic acid production). 
Additionally, when artificial caries lesions are induced, response variables included mineral loss assessment (transverse microradiography, percentage of surface hardness change, scanning electron microscopy, and polarized light microscopy).
In a biofilm model, it is important to quantitatively express the prevalence of 
specific groups of microorganisms to better understand their relationship to the tested experimental conditions. To achieve this goal, most of the reported studies 
used classical bacterial identification methods based on the cultivation of strains on agar plates and the determination of CFU counts (Shu et al. 2000; Giertsen et al. 
2011; Smullen et al. 2012; Schwendicke, Horb, et al. 2014; Vanni et al. 2015). Although 
this method has been widely used, the significance of the data is limited by the 
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total counts of bacteria (irrespective of the genus) or the counts of specific strains. 
This method seems to be less representative for microcosm biofilms since it may underestimate the counts of some important strains (Rudney et al. 2012). This lack of information impairs understanding of the ecological role of microorganisms and 
of the metabolic profile of biofilms during caries lesion development. In this context, only four of the reported studies in Part II (based on the microcosm inoculum) used 
molecular biology methods for the identification of the biofilm microbial content (McBain et al. 2003a, 2003b; Zaura et al. 2011; Cavalcanti et al. 2014).New approaches, including metagenomic, metatranscriptomic, metaproteomic, 
and metabolome analysis of the oral biofilm, may improve understanding of the microbial community and the ecology of caries (Nyvad et al. 2013; Takahashi 2015); 
thus, future studies examining in vitro biofilm models should also focus on the 
ecological and metabolic evaluations of a biofilm.
Risk of bias assessmentThis review found that most studies showed a high (16) or medium (28) risk of bias based on the method used for the risk of bias assessment, as described in Table 2. 
Dynamic models showed a higher risk of bias than the batch model. This finding is not related to the complexity of the models but to how the experiments were performed and reported. It is worth mentioning that studies should be performed 
with sufficient methodological detail to allow a risk of bias assessment.A low bias risk was only found in the models reported by Cavalcanti et al. (2014), Fernández et al. (2015), Giacaman et al. (2015), Fernández et al. (2016), and Maske et al. (2016); however, these studies did not mention the sample size calculation. The absence of information in the evaluated studies may not imply the authors did 
not carry out those procedures, but it precludes verification by the reader. In this sense, there is a need for reporting guidelines for in vitro research to improve the quality and transparency of studies (Sarkis-Onofre et al. 2015).
Final considerations
The development of laboratory biofilm models is essential for the advancement 
of pre-clinical caries research. Several biofilm models have been proposed, and 
it is difficult to determine which is superior for a specific research question. This review was designed to summarize the current evidence regarding the more 
comprehensive biofilm models described in the literature. This summarized information may help researchers when choosing which parameters to adopt in 
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future studies. It is important to note, however, that most of these models are distinct from the complexity of the oral environment and only reproduce a small number of the possible events that may occur in vivo.A general recommendation regarding the choice of model parameters for future research is to select models that are simpler for initial screening tests or for ‘proof 
of principle’ questions and more complex simulation conditions for final pre-clinical testing of the hypothesis before in situ studies or clinical trials.
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Abstract
This in vitro study investigated the development of dentin wall lesions next to 
resin composite containing very small gap sizes using an in vitro biofilm model, and evaluated whether a relevant threshold for the gap size could be established. 
Microcosm biofilms were grown for 14 days within small interfacial gaps between dentin-resin composite discs under intermittent cariogenic challenge. The factor under study was gap size: samples were either restored with composite resin without adhesive procedure (no intentional gap; no bonding [NB] group) or with 
intentional gaps of 30, 60, or 90 μm, or with complete adhesive procedure (no gap; bonding [B] group). Secondary caries wall lesion progression was measured in lesion depth (LD) and mineral loss (ML) using transversal wavelength independent microradiography at 3 locations: outer surface lesion and wall lesions at 200 and 
500 μm distance from gap entrance. Results from linear regression analysis showed 
that the presence of an intentional gap (30, 60, and 90 μm) affected the secondary 
caries progression at 200 μm from the gap entrance (p ≤ 0.013). The NB group did 
not show significant wall lesion development (ML and LD, p ≥ 0.529). At 500 μm distance almost no wall caries development was observed. In conclusion, dentin wall lesions developed in minimal gap sizes, and the threshold for secondary wall 
lesion development was a gap of around 30 μm in this microcosm biofilm model.
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3.1 IntroductionS econdary caries has been considered as one of the most common reasons for the failure and replacement of posterior restorations [Mjor et al., 2000; Demarco et al., 2012; van de Sande et al., 2013; Opdam et al., 2014]. It has been assumed that secondary caries lesions develop both as outer lesions on the tooth surface next 
to the restoration and as wall lesions within the tooth-restoration interface [Hals and Nernaes, 1971].The current literature is still unable to determine the precise mechanism of 
secondary caries initiation and progression. However, one of the possible factors is the existence of a gap or defect at the cavity wall. For a long time, leakage between the tooth and restoration was considered as a risk factor for wall lesion initiation and progression [Gonzalez-Cabezas et al., 1995, 1999, 2002]. According to the microleakage theory, secondary caries could develop in any gap, but the wider the gap, the higher the risk that secondary caries could occur [Totiam et al., 2007].Nevertheless, in clinical studies microleakage did not seem to be associated with secondary caries, and therefore the macroleakage theory started to be accepted. 
According to this theory, wall lesions will only develop when large gaps (225 μm 
or more) or cavities are present [Kidd et al., 1995; Thomas et al., 2007; Totiam et al., 2007].Several recent studies showed that secondary caries lesions could develop in 
smaller gaps than originally thought [Kuper et al., 2014; Khvostenko et al., 2015; 
Turkistani et al., 2015]. Kuper et al. [2014] observed wall lesions in gaps with a width 
of around 70 μm, but a threshold for the minimal gap size in which wall lesions could develop was still not established. If such a threshold exists, it will most likely be 
found in the range of about 10–70 μm. Thus, this in vitro study aimed to evaluate dentin wall lesion development next to resin composite in very small gap sizes and to evaluate whether a relevant threshold for the gap size could be established. The hypothesis tested was that in minimal gaps secondary caries would develop and 
that the size of the gaps would influence the lesion depth (LD) and mineral loss (ML) of wall lesions.
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3.2 Material and Methods
Ethical approval was granted by the local Ethics in Research Committee (School of Dentistry, Federal University of Pelotas, Pelotas, RS, Brazil) under protocol No. 1.634.686/2016.
Sample Size CalculationSample size was calculated with data of wall lesion progression in gaps (0 and 100 
μm) from a previously published study [Kuper et al., 2014], using the Power and Sample Size Program© (version 3.1.2, 2009). Power was set at 80% and type I error 
at 5%. This resulted in a sample size of 8 specimens per group. However, considering a 20% dropout rate due to the complex design of the sample preparation, a total of 10 samples per group was made.
Sample Preparation and Restorative ProceduresSample preparation and restorative procedures are shown in Figure 1. Enamel-dentin discs were cut from the buccal surface of 25 freshly extracted sound bovine incisors using a water-cooled trephine drill. The enamel was removed by wet polishing with 80-grit SiC abrasive paper. To standardize the smear layer, samples were wet polished with 600-grit SiC paper for 1 min. The dentin discs were sectioned 
into 2 halves that were restored with resin composite (Filtek Z250 XT; 3M ESPE, St. Paul, MN, USA) according to the following conditions:
Complete Adhesive Procedure: Bonding (B). The bottom (pulpal) and interfacial sides of the dentin were etched with a 35% phosphoric acid gel (15 s, Ultra-
Etch®; Ultradent Products Inc., South Jordan, UT, USA), a bonding agent was applied (AdpterTM Single Bond 2; 3M ESPE) and polymerized according to the manufacturer’s instructions. Subsequently, the halves were inserted in an acrylic mold (2.5 mm thickness and 6 mm diameter), restored with composite resin and polymerized (20 s), resulting in a round specimen: half dentin and half composite at the surface, with a connecting composite layer of 1 mm at the bottom.
Without Adhesive Procedure: No Bonding (NB), 30, 60, and 90 μm. These samples were restored with composite in the same way as previously described, except that a central square window (3 mm2) at the interface did not receive any adhesive procedure. At this square window either no matrix was used (NB group) or a metal 
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matrix with standard width (2.0 mm) and different thicknesses (30, 60, and 90 μm) was placed against the interfacial wall during composite placement, creating an intentional gap (Figure 1 b).
Figure 1. a Dentin preparation: dentin discs and halves prepared. b Restorative procedures. Left side: arrows indicate the areas which were etched with 35% phosphoric acid per group. Right side: placement of composite. Note the use of metal matrix for groups with gaps. c Final representation of the samples. Left side: samples with gaps. Right side: samples without intentional gaps. Note that the complete sample is covered by nail varnish except the square window around the interface between the dentin and resin composite.
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After the restorative procedures, the final samples were covered with nail varnish except a central square window (2.0 × 2.0 mm) at the sample surface, 
incorporating the gap area (Figure 1 c). The gaps were measured with a WF10X 
lens (Future-Tech Corp., Tokyo, Japan) coupled to a microhardness tester (FM 700; 
Future-Tech Corp.) at 3 different locations: 200 μm from each edge and in the middle 
of the gap (1,000 μm from edge) as shown in Figure 2 a.
Figure 2. a Locations of gap measurement (a and c = 200 μm from each edge; b = 1,000 μm from edge – middle position). Dashed lines represent the section that was used for T-WIM (1 mm). b Section cut from the dentin-resin composite sample and the locations of T-WIM 
measurements: 1 (surface lesion: 400 μm from interface), 2 (200 μm from the surface / gap 
entrance), 3 (500 μm from the surface / gap entrance) and SD (sound surface area –control).
Sterilization of SamplesThe samples were sterilized by gamma radiation in the Regional Center of Oncology/Radiotherapy Service, Faculty of Medicine, Federal University of Pelotas, Pelotas, Brazil. All samples were kept moist in distilled water inside microtubes, placed at 2 cm from the radiation source, and subsequently submitted to sterilization with gamma radiation from a cobalt-60 source with particle energies of 1.25 MeV and 
609.25 Gy/min, with a total dose of 4.08 KGy.
Microcosm Biofilm Model
Fresh whole saliva stimulated by paraffin film chewing (20 mL) was collected from a healthy volunteer (male, age 24 years) who had not been under antibiotic therapy for at least 6 months. The volunteer abstained from oral hygiene for 24 h and from food ingestion for 2 h prior to collection. A 0.4-mL volume of saliva was used to inoculate each dentin-restoration disc placed in a 24-microwell plate, and it remained at rest 
at 37°C. After 1 h, 1.8 mL of defined medium enriched with mucin (DMM) [Wong 
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and Sissions, 2001] containing 1% sucrose was added. The plates were incubated at 37°C under an anaerobic atmosphere (5–10% CO2, less than 1% O2). After 6 h, the samples were rinsed with 2 mL of sterile saline, inserted into a new plate containing DMM without sucrose, and incubated for 18 h under the same conditions. 
The biofilms were formed individually on the discs in each well for 14 days, during which the same daily routine of alternate exposure to DMM supplemented with sucrose (DMM+S) and without sucrose (DMM) was followed [van de Sande et al., 
2011; Maske et al., 2015; Montagner et al., 2016]. The final pH of DMM+S and DMM medium was 4.6 ± 0.05 and 7.1 ± 0.07, respectively.
Transversal Wavelength Independent MicroradiographySecondary caries lesion development was evaluated using transversal wavelength independent microradiography (T-WIM). A 1-mm section was cut from each sample through the interface. Microradiographs were taken of the sections with an exposure time of 12 s and settings of 40 kV and 20 mA. A step wedge with the 
same absorption coefficient as the dentin (94% Al/6% Zn alloy) was used for proper 
quantitative measurement of LD (μm) and ML (μm × vol%). After X-ray exposure, the 
films were developed (10 min), fixed (7 min), rinsed (30 min), and dried. A digital image of each sample was captured using a light microscope (Leica Microsystems, 
Wetzlar, Germany) with a magnification of 10× and a CMOS camera (Canon EOS 
50D, Tokyo, Japan). LD and ML for T-WIM were measured with a software program 
(T-WIM calculation program, version 5.25; J. de Vries, Groningen, The Netherlands) 
at 3 locations: surface lesion (400 μm distance from interface), and at 200 and 500 
μm distance from the entrance of the gap.As a control, LD and ML values were also determined from the sound surface (Figure 2 b).
Statistical AnalysisThe correlation between ML and LD was determined with a Pearson correlation analysis. The effect of interface conditions on ML and LD were separately analyzed by 
linear regression models per location (surface lesion, and 200 and 500 μm distances from gap entrance) using the statistical software package SPSS (Statistical Package 
for Social Sciences, version 20.0, Chicago, IL, USA). The statistical significance was set at p < 0.05.
3
82
Chapter 3
3.3 Results
The average gap size per group was as follows: NB = 13.6 ± 0.43 μm; 30 μm = 36.8 
± 1.33 μm; 60 μm = 64.2 ± 1.52 μm; and 90 μm = 94.0 ± 1.30 μm.The average values for LD and ML considering each gap condition at the 3 locations are shown in Figure 3. LD and ML sound surface values were 49.1 ± 13.8 and 1,109.4 ± 246.0, respectively, and the range for sound values is indicated in Figure 3 by a rectangular box. Surface lesions showed highest ML and LD values. Dentin wall lesions were lower, with substantial lesion formation only in the 
intentional gaps at 200 μm from the surface.The Pearson correlation analysis showed a high correlation between LD and ML data (R > 0.906).Results from the linear regression analysis are shown in Table 1. The presence 
of intentional gap conditions significantly influenced the secondary caries lesion 
progression at 200 μm from the gap entrance (p < 0.013), whereas NB did not affect 
the lesion progression (p ≥ 0.529). The effect on secondary caries progression was 
observed from the 30-μm gap size. At a distance of 500 μm from the gap entrance, 
only the gap size of 60 μm showed statistically significant lesion formation.
83
Minimal gap size and wall lesions
Figure 3. Bar charts showing the lesion depth (a) and mineral loss (b) values for each in-terface condition and area of analysis. Rectangular boxes represent the lesion depth and mineral loss sound surface values for reference: 49.1 ± 13.8 and 1,109.4 ± 246.0, respectively. 
Asterisks represent those interface conditions with a significant effect on secondary lesion development within each location evaluated (bonding vs. interface). SL, surface lesion.
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Table 1. Linear regression of lesion depth and mineral values considering the gap condition in each area of analysis.
Area of 
analysis
Lesion Depth (µm) Mineral Loss (µm.vol%)
Variable Effect
p 
value
95% CI of effect
Effect
p 
value
95% CI of effect
Lower Upper Lower Upper
Surface 
Lesion 
(SL)
Intercept* 120.675 - 107.525 133.825 2638.50 - 2272.01 3004.99
NB 2.263 .807 -16.334 20.859 24.00 .926 -494.29 542.29
30 µm 13.925 .138 -4.671 32.521 429.89 .101 -88.42 948.17
60 µm 21.625 .024 3.029 40.221 663.88 .013 145.58 1182.17
90 µm 9.575 .279 -8.067 27.217 326.50 .187 -165.19 818.19
Adj r2=.075 Adj r2=.121
200µm 
from 
surface
Intercept* 45.437 - 25.718 65.157 1026.63 - 675.78 1377.47
NB 5.650 .684 -22.238 33.538 155.50 .529 -340.67 651.67
30 µm 36.075 .013 8.187 63.963 425.38 .091 -70.80 921.55
60 µm 73.250 .000 45.362 101.138 1075.63 .000 579.45 1571.80
90 µm 60.253 .000 33.796 86.709 852.68 .001 381.97 1323.39
Adj r2=.505 Adj r2=.376
500µm 
from 
surface
Intercept* 50.487 - 34.229 66.746 1038.38 - 729.10 1347.66
NB 10.600 .356 -12.393 33.593 267.38 .223 -170.01 704.76
30 µm 4.475 .696 -18.518 27.468 271.38 .217 -166.01 708.76
60 µm 22.063 .060 -.930 45.055 470.75 .036 33.36 908.14
90 µm 10.093 .355 -11.720 31.905 307.03 .142 -107.92 721.97
Adj r2=.007 Adj r2=.022* Bonding group was used as reference group for analysis.
3.4 Discussion
This in vitro study showed that wall lesions can develop in dentin next to resin composite containing very small gaps and that the minimal gap size (threshold) for 
its development seems to be around 30 μm.In this study, samples in the B group represent the best feasible interface condition where no or unavoidable small marginal defects are present and therefore the development of wall lesions was not expected. As interfacial gaps have been considered a crucial factor to secondary caries lesion formation [Totiam et al., 2007; 
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Diercke et al., 2009; Kuper et al., 2014], etching and bonding agents were omitted to induce a minimal gap in the NB group and enable wall lesion formation. Although 
a minimal gap was present in the NB group (13.6 ± 0.43 μm), secondary caries wall lesions were not observed there. As expected, samples in the B group also did not show any wall lesion development. LD and ML values presented in these groups were comparable to sound surface values (control) and are related to the T-WIM technique. In this method, an offset from zero and minimum unsharpness are unavoidable [Thomas et al., 2006]. The effect of gap size on secondary caries wall 
lesion formation was significant from 30 μm. Thus, the secondary caries progression 
seems to start from a gap size of between 13 and 30 μm. These results support the hypothesis that secondary caries can develop in the presence of very small gaps and that a threshold gap width may exist.
Recently, Khvostenko et al. [2015] showed that a viable biofilm could be formed 
inside small simulated interfaces varying in size from 15 to 30 μm. Our results are 
in agreement, with caries formation from a gap width of 30 μm.
The present findings do not support the clinical theory that large gaps (macroleakage) are needed for secondary wall lesion development [Mjor, 2005]. Two wall locations were analyzed in this study. The secondary wall lesions found 
in the first location (200 μm from gap entrance) showed clear lesion formation with 
intentional gap sizes while the deepest location (500 μm from gap entrance) showed hardly any lesion formation. This can be explained by the fact that access of bacteria deeper into the gap is more challenging and takes longer, especially when there is no loading involved. Cyclic loading helps bacterial penetration due to a hydraulic 
pumping effect [Khvostenko et al., 2015; Nedeljkovic et al., 2015]. If the gap closes and opens under the cyclic loading, it transports fresh media and bacterial cells into the gap, while possibly removing some of the saturated solution and bacterial waste 
from the gap [Khvostenko et al., 2015]. In addition, longer distances could decrease the rate of nutrients reaching the deeper parts of the gap as well as clearance of the demineralization products [Nassar and Gonzalez-Cabezas, 2011; Schwendicke et al., 2016]. Minerals dissolved from the tooth structure due to the acid attack would remain in the small gap, increasing the saturation level of the area, and therefore also limiting the progression of wall lesions [Totiam et al., 2007; Nassar and Gonzalez-Cabezas, 2011].An increment of LD and ML was expected with the increase of gap size, but it was 
not observed in the present study. In a previous in vitro study, Kuper et al. [2015] found an association between gap size and wall lesion development using the same 
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biofilm model. However, in that study gap sizes varied roughly between 213 and 578 
μm. In the present study we focused on finding a threshold and for that reason the 
gap sizes were very small and only ranged between 30 and 90 μm. It is much more 
unlikely to find an association over such a small range. The small range between gap 
sizes as well as the variability of biofilm formation on samples inherent to biological models could also explain the slightly higher secondary caries lesion formation at 
gap sizes of 60 μm than at those of 90 μm.
For this study a short-term microcosm biofilm model was used with a high cariogenic challenge regimen and saliva of only one person as inoculum. From previous studies we knew that this saliva was able to reproducibly induce caries 
lesions. However, we know that the disadvantage is that no interpersonal variation was simulated in this study. Considering these facts, it is interesting to point out 
that the secondary caries development shown here reflects a high cariogenic 
challenge and the internal capability to induce caries from that specific saliva 
donor. However, other studies have consistently shown that regardless of the type 
of inoculum, this biofilm model can produce similar caries-like lesions [Azevedo et al., 2011, 2014; Signori et al., 2016]. Further research should use in situ models to obtain intrapersonal variations on caries susceptibility. Another limitation of 
this study is that in this biofilm model, no fluoride was used in the artificial saliva 
(DMM). Fluoride delivered from the medium (representing fluoride from other sources inside the mouth) may have some preventive effect in the secondary caries development in these small gaps.Within the limits of the present study, we conclude that the minimum gap size 
for secondary caries wall lesion development may be as small as 30 μm in this 
microcosm biofilm model.
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A threshold gap size for in situ secondary caries 
lesion development
This chapter will be submitted in Journal of Dentistry as: Maske TT, Kuper NK, 
Hollanders A, Bronkhorst EM, Cenci MS, Huysmans, MCDNJM (2018). A threshold gap 
size for in situ secondary caries lesion development.
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Abstract
Objectives: This in situ study aimed to investigate the influence of very small gaps in SC development and additionally to link the level of SC and a threshold gap size with the caries activity level of the volunteer.
Methods: For 21 days, 15 volunteers wore a modified occlusal splint loaded with dentin-composite samples restored according to different interface conditions: bonded (B = samples restored with complete adhesive procedure), no-bonded (NB = restored with composite resin without adhesive procedure), and 30, 60 and 90 µm (no adhesive procedure and with intentional gap). Eight times per day, the splint with samples was dipped in a 20% sucrose solution for 10 minutes. Before and after caries development, samples were imaged with T-WIM and lesion depth and mineral loss were calculated. Volunteers were grouped according to the average wall lesion 
depth and classified as high, mid and low caries activity levels.
Results: No wall lesion formation was observed in B and NB groups. In general, intentional gaps led to SC lesion depth progression independent of caries activity level of volunteers. No substantial wall lesions were found for two volunteers. A trend for deeper lesion in larger gaps was observed for the high activity group.
Conclusion: Very small gaps around or wider than 30 µm develop SC independent of the caries activity level of the patient and SC wall lesion progression seemed to be related to individual factors even in this standardized in situ model.
Significance: Independently of caries activity level of the patient, the threshold gap size for secondary caries wall lesion seems to be around 30 µm.
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4.1 IntroductionS econdary caries is defined as a carious lesion developing adjacent to a restoration margin (Mjor, 2005). The presence of cariogenic biofilm in association with a discontinuity / gap at the restoration margin is considered a crucial factor for secondary caries lesion development (Carvalho and Manso, 2016; Ferracane, 2017).Macroleakage is the most accepted theory to explain secondary caries 
development (Nedeljkovic et al., 2015). By this theory the width needed for biofilm 
development inside the gap should be large enough to harbour a cariogenic biofilm, 
sometimes estimated at larger than 225 µm (Kidd et al., 1995; Thomas et al., 2007). Recently, however, a group of in vitro and in situ studies have questioned this theory 
(Khvostenko et al., 2015; Kuper et al., 2014; Maske et al., 2017; Turkistani et al., 2015). These studies have shown that the width of gap required for secondary caries wall lesion development may well be smaller than this macroleakage theory 
proposes. Khvostenko et al. (2015) showed that gap sizes with ~15 µm were able 
to accumulate biofilm. In addition, Maske et al. (2017) showed that secondary wall lesions developed in vitro in very small gap sizes and suggested that a minimum 
gap size for lesion formation would be around 30 µm. Although these findings undermine the prevailing theory they still need complementary validations by clinical in situ studies.In an in situ study focused on gap sizes and secondary caries development, it could be observed that although all subjects were exposed to a highly cariogenic protocol which should result in rapid caries progression, the level of wall lesion development varied greatly among the subjects. This suggested that gap width may be irrelevant where caries risk is low, but that when caries risk is high, a gap size 
of around 70 µm could suffice for secondary caries wall lesion formation (Kuper et al., 2014). This assumption could also imply that a minimum gap size (threshold) for secondary caries lesion development could be related to caries risk / activity caries level of the patient.
The present in situ study therefore aimed to investigate the influence of very small gaps between tooth and restoration in the secondary caries development and additionally to link the level of secondary caries and a threshold gap size with the caries activity level of the volunteer. The hypotheses raised in this study were that: i) secondary wall lesion would develop in very small gap sizes and ii) a high caries activity level would be related to secondary wall lesion development in the smallest gaps and a low caries activity related to lesion progression only in bigger gaps.
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4.2 Material and Methods
Study participantsThe protocol and design of this study were submitted to and approved by an Ethical Committee Board (CMO code NL 56622.091.16). All volunteers agreed and signed 
the written informed consent. Sixteen volunteers (five men and eleven women, aged 18–52 yr, mean age = 28.4 yr) with good general health were recruited within the Campus of Radboud University (Nijmegen, The Netherlands). Volunteers with active caries, periodontitis (DPSI > 2), ASA > 2, and wearing orthodontic or a removable prosthetic appliance in the mandibular jaw were excluded.
Sample preparation
Sound human molars were collected and ground flat using a 220-grit Sic paper on polishing wheel until complete enamel removal and dentin exposure of the coronal tooth surfaces (occlusal, proximal and smooth). A diamond saw was used to cut off the roots (Buehler diamond wafering blade nr.11-4244) and the remaining crowns 
were cut perpendicularly into two dentin bars with fixed width of 3.2 mm and varying lengths (Figure 1A-B). Subsequently the dentin bars were manually ground with 400-grit Sic paper to a height of 2.0 mm and gas-sterilized with ethylene 
oxide (Isotron Nederland B.V., Venlo, The Netherlands) (Kuper et al., 2014). Using a rectangular putty mould a long dentin-composite sample (15 mm) was created 
by attaching two dentin bars together on a thin layer of composite (0.5 mm) fixed 
with self-etching primer and bonding agent (SE Bond, Clearfil, Kuraray, Okayama, 
Japan) on the pulpal side. In each dentin-composite sample, five slots were made parallel to the dentin tubule with a 0.12 cylindrical bur with a depth of 1.9mm. Three 
slots were filled with resin composite (AP-X PLT, Clearfil, Kuraray, Okayama, Japan) without any adhesive procedures and a small gap was created by placing a metal matrix of 30, 60, or 90 µm thickness between the dentin and the composite. One slot 
was filled completely with composite, but no adhesive was used (no-bonded). The 
remaining fifth slot was restored with composite and adhesive procedure according to manufacturer’s instructions (bonded, control group) (Figure 1C-E).
A modified occlusal splint for mandibular jaw (Figure 1F) with four metal slots (20 mm x 3.2 mm x 2.5 mm) containing dentin-composite samples was delivered to each volunteer. The samples described in this study were always located in the lower slots, but the left and right side were alternated per volunteer. Also the positions 
of different composite-dentin interfaces (B, NB, 30, 60 and 90 μm) were modified 
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between the volunteers (mesial to distal). The rotation of samples positions (more mesial or distal) and the side of the device (right or left) were manually generated 
using computer software (Microsoft Office Professional Plus 2010 Excel Program). The upper slots and their samples were used for one parallel study aiming to 
evaluate effect of a metalloproteinase inhibitor (2 % CHX solution) on secondary caries lesion development (Maske et al. 2018). The antimicrobial effect of that inhibitor was inactivated using a neutralizing solution (D/E Neutralizing Broth, Acumedia, Michigan, USA) to avoid residual effect on the present study.
Experimental protocolFor 21 days, volunteers wore the occlusal splints (24 h per day), removing them only for eating, drinking, sports or oral hygiene and keeping them in physiological salt solution during those periods. The splints were dipped in 20% sucrose-solution eight times per day for 10 min and with 1h intervals at least. The exact moments of sucrose exposure was recorded by each volunteer in a diary. After sucrose dipping, the splints were rinsed with tap water and immediately replaced in the mouth. All 
volunteers used fluoride dentifrice (1450 ppm; Colgate Caries Protection, Colgate-
Palmolive-Company, The Netherlands) and once a day fluoride dentifrice slurry was applied on the samples for 2 min when they brushed their teeth. The slots 
containing the samples were not cleaned or brushed to promote biofilm formation and caries lesion development. Instructions were given both orally and in writing by a researcher involved in the study.
Transversal wavelength independent microradiography (T-WIM)T-WIM pictures were carried out at baseline (T0) and after 21 days (T21). The settings for the microradiographs were 45 kV, 40mA and 8 s of x-ray exposure. A stepwedge (94% Al/6% Zn alloy) was used for quantitative measurement of LD and ML.
After x-ray exposure, films were developed (10 min), fixed (7 min), rinsed and dried. Digital images of each sample were recorded with a light microscope (Leica 
Microsystems, Germany) with a magnification of ×10 and a CMOS camera (Canon 
EOS 50D, Japan). The T-WIM pictures were edited using Adobe Photoshop CS6 (v. 
13.0, Adobe Systems, San Jose, CA, USA) to distinguish between gaps and caries lesions. The contour of the interfaces on the baseline (T0) images was selected and copied to second T-WIM image (T21) to calibrate the pictures. Subsequently, the selected contour was coloured black to allow caries lesion development to be 
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identified and distinguished from gap width (Kuper et al. 2014). Wall lesions in the dentin around the gaps were measured using a software program developed by 
our laboratory at a fixed area 400 μm under the surface. Baseline measurements (T0) were subtracted from measurements taken from pictures after 21 days (T21) to estimate the true LD and ML values. The same software program was used to measure the actual gap sizes (30, 60 and 90 µm) from baseline T-WIM images as 
described elsewhere (Kuper et al. 2014).
Statistical analysisDescriptive statistics were used to analyse mineral loss (ML) and lesion depth (LD) data for all interface conditions and volunteers. In order to evaluate a possible relationship between caries activity levels and threshold gap size for wall lesion development, the volunteers were grouped into 3 equal groups (n=5) according to the average wall lesion depth in intentional gap sizes (30, 60 and 90 µm) and 
classified as high, mid and low caries activity. The relationship among caries activity level, gap size and wall lesion depth was also analysed descriptively.
Figure 1. Preparation of samples and overview of study: A) 1- Complete enamel removal and dentin exposure. 2- Roots are cut off. 3- Dentin bar are made by cutting. B) Dentin bars (2 mm thickness and 3.2 mm width). C) Two dentin bars were attached together with a thin layer of composite to obtain a dentin-composite sample. D and E) Five slots are made in the dentin-composite sample and restored with resin composite according to interface condition (Bonded-B, No-bonded-NB, 30, 60 and 90µm). F) Splint was loaded with dentin-compos-ite-samples. G) After experimental running, sample were analysed by TWIM.
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4.3 Results
Fifteen volunteers completed the study in 21 days. One volunteer did not comply with the study protocol and was therefore excluded from data-analysis. In addition, 3 volunteers had one sample excluded from B or NB group because the enamel layer had not been completely removed during sample preparation.Actual gap sizes are presented in Table 1. Average values of LD and ML considering all volunteers included in the study are also shown in this table. In general, dentin wall lesion development was seen when intentional gap sizes were present. No considerable wall lesion formation was observed in B and NB condition.
Table 1. Mineral loss (ML) and Lesion Depth (LD) values considering all volunteer vs. interface condition per lesion location evaluated.
Interface 
condition
Actual gap 
size (µm)
Mean ± SD
Wall lesion
Mean ± SD
Surface lesion
Mean ± SD
LD (µm) ML (µm.vol%) LD (µm) ML (µm.vol%)
B - 3.7 ± 7.4 16.6 ± 451.3 69.1 ± 57.8 841.5 ± 938.2
NB - 2.6 ± 7.8 196.5 ± 327.3 52.8 ± 56.8 721.3 ± 915.4
30 µm 45.5 ±10.5 57.2 ± 44.9 904.1 ± 658.0 45.7 ± 53.4 857.4 ± 1050.7
60 µm 72.2 ± 9.4 83.8 ±57.6 1289.3 ± 1113.5 40.6 ± 43.0 689.2 ± 725.5
90 µm 103.5 ±4.6 82.3 ± 69.4 1483.9 ±1399.5 43.7 ± 32.3 1014.8 ± 666.7
Note: B [n= 14] / NB [ n=13] / 30, 60 and 90 µm [n= 15].Figure 2 shows the relationship between secondary caries wall lesion depth and threshold gap sizes according to caries activity levels. In general, the presence of an intentional gap, even the smallest one, led to secondary caries wall lesion depth progression. A trend for deeper lesions in larger gaps could only be observed for the high caries activity group. In two volunteers there were no substantial wall lesions in any interface condition evaluated.
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Figure 2. Secondary caries wall lesion depth results for all (measured) gap sizes regarding the caries activity level of volunteers.
4.4 Discussion
This is the first in situ study trying to find a relationship between threshold gap size for secondary caries wall lesion development and caries activity level of the patient. The present study showed that secondary caries wall lesions occurred independently of caries activity level when a gap size around or wider than 30 µm was present. The second hypothesis raised in this study was therefore not supported.In this study, the best feasible interface condition, ideal bonding, was represented by samples from group B. To introduce the smallest possible gap size, etching and bonding agents were intentionally omitted in samples assigned to NB group. As expected, samples in the B group did not show any wall lesion development. Similarly, no considerable wall lesions were observed in the NB group. Although the method used to measure the gap width in this study was unable to determine the very small space between tooth and restoration in the NB condition, other studies have reported that this condition represents around 7 to 13 µm gaps (Cenci et al., 2008; Maske et al., 2017). Considering the existence of such minimal space in NB 
group, the ML and LD results confirm that a gap size, larger than 7-13 µm, is needed to secondary caries wall lesion development.
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This study confirmed that a gap size of about 30 µm was sufficient for the development of secondary caries wall lesion and thus supports the hypothesis that wall lesions may develop in very small gaps and that a threshold gap width around 30 µm may exist (Maske et al. 2017). When data were individually split by volunteers it was noticed that, independently of caries activity level, wall lesions developed in very small spaces (> 27.4 µm). This implies that the presence of a minimal gap size is the critical factor to develop secondary caries wall lesion.
Obviously subjects classified as low, high or mid secondary caries activity level demonstrated different patterns of lesion depth progression. Figure 2 illustrates the differences in lesion development across subjects. If all subjects were exposed to the same cariogenic protocol (20% sucrose, 8 x per day), what may explain this large variation? It must be assumed that there are individual factors (either protective or risk factors) that modulate the lesion progression at least in gap sizes around and from 30 µm. It may be hypothesized that substantial gaps may be a risk factor for secondary caries development only in individuals with an elevated caries risk 
profile. This hypothesis could also explain why 2 volunteers did not show any wall 
lesion depth progression, and it is supported by observations by Kuper et al. 2014, where the pattern of lesion progression was also variable among subjects enrolled in that in situ study.A trend for larger wall lesion with wider gaps was observed in high caries activity patients in this in situ study. It is worth to be mentioned it could be related to caries activity level criteria used in this study, but it could be also related to 
more biofilm accumulation in the space between tooth and restoration (Kuper et al., 2015; Totiam et al., 2007) and related to an individual capability to modulate the development of secondary caries lesion.
Although this study was limited by use of a simplified method to classify caries 
activity level of each volunteer, the above-mentioned findings acknowledge that 
dentists should clinically consider the patient’s individual risk profile. The marginal defect seems to be a crucial factor for secondary lesion development (Diercke et al., 
2009; Kuper et al., 2014; Totiam et al., 2007), but only focusing on gap size may be 
an oversimplification.Within the limitations of the present study, we concluded that: i) secondary caries lesions develop in very small gaps, ii) the threshold gap size for secondary caries wall lesion seems to be around 30 µm independent of caries activity level of the patient and iii) secondary caries lesion progression seems to be related to individual factors even in a standardized in situ model.
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Abstract
This study investigated the role of MMP inhibitor (2% CHX) in secondary caries wall lesion development in different interface conditions with small (run 1) and wider gaps (run 2). Dentin discs were restored and pre-treated with or without chlorhexidine 2%. In run 1, interfaces were made with gaps of 30, 60 or 90 µm. Interfaces with composite placed directly onto the dentin were either bonded (Adpter Single Bond 2) or not bonded. In run 2, interfaces were made with gaps 
of 100 µm, with or without adhesive on the composite side (Clearfil SE Bond). 
Interfaces were either bonded or not bonded as in run 1. Microcosm biofilms were grown on dentin-composite samples (14 days). Caries lesion outcomes were analysed by transversal wavelength independent microradiography (T-WIM) at three locations: outer surface and interface wall (200 and 500µm distance from gap entrance). Linear regression analyses showed that pre-treatment with MMP 
inhibitor did not influence the wall lesion progression at either location (p ≥ 0.218). 
Interfaces with intentional gaps showed positive and significant effect on the wall 
lesion progression at 200 µm distance from the gap entrance (p ≤ 0.005). A small trend of increase in wall lesion development was observed at the 200 µm location when bonding was present on the composite side. In conclusion, the dentin pre-
treatment with MMP inhibitor (CHX 2%) was not able to slow down the secondary 
caries wall lesion development in small and wide gaps in this biofilm model.
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5.1 IntroductionD entin is a collagen-based mineralized tissue consisting of inorganic apatite crystallites embedded in an extracellular matrix [Linde, 1989]. Approximately 10% of this matrix is composed by noncollagenous proteins that include proteoglycans, phospholipids, and enzymes. Among these enzymes, the matrix metalloproteinases (MMPs) have recently received more attention. MMPs are a family of Zn+2 - and Ca+2 -dependent endopeptidases and are capable of degrading collagenous dentin proteins [Visse and Nagase, 2003; Mazzoni et al., 2015].MMPs are involved in dentin caries progression and collagen degradation in the adhesive hybrid layer under composite restorations [Tjaderhane et al., 1998; Tjaderhane et al., 2013; Mazzoni et al., 2015]. In a mineralized state (sound substrate), the MMPs remain inactive, but they can become activated by acids delivered from cariogenic bacteria and/or acidic materials used in restorative procedures such as phosphoric acid and acid monomers [Pashley et al., 2004]. Self-etching and etch-
and-rinse adhesives remove mineral crystals around collagen fibrils (exposing 
the collagen) to provide space for bonding infiltration, but simultaneously trigger MMP activation [Tjaderhane et al., 2013; Mazzoni et al., 2015]. In dentin caries 
progression, the acidic environment created by cariogenic biofilm can have a similar result [Tjaderhane et al., 1998; Mazzoni et al., 2015; Takahashi and Nyvad, 2016]. MMPs activated by bacterial acid may initiate a partial degradation of the exposed tooth organic materials. Once the organic degradation starts, complete 
remineralisation may no longer be possible [Kuboki et al., 1977; Takahashi and Nyvad, 2016].In dentin matrices, MMP activity can be reduced by endogenous and exogenous inhibitors. Endogenous inhibitors originate from different human cells, while exogenous inhibitors are synthesized as therapeutic agents. Most of these inhibitors chelate calcium or replace the zinc ions at the active site and/or interact with the MMP propeptide fragment, while others may prevent MMP access and inhibit activity by coating the substrate [Tjaderhane et al., 2013; Mazzoni et al., 2015].
One potent exogenous inhibitor is chlorhexidine (CHX) which reduces the activity of MMPs by chelating mechanism [Gendron et al., 1999]. Through this mechanism, ions such as Ca+2 and Zn+2 are sequestered and the catalytic activity of MMPs doesn’t 
evolve [Sorsa et al., 2004]. CHX has been shown to preserve bond stability even at 
concentrations as low as 0.2% [Carrilho et al., 2007a; Komori et al., 2009; Breschi et al., 2010; Montagner et al., 2014]. In addition, in situ studies have also demonstrated 
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that gels or solutions delivering CHX are able to prevent dental demineralization 
caused by erosion [Magalhaes et al., 2009; Kato et al., 2010]. These observations suggest that approaches to avoid organic matrix degradation might also be useful in caries prevention [Tjaderhane et al., 2015; Takahashi and Nyvad, 2016].As MMPs are involved in dentin caries progression and collagen degradation of 
the hybrid layer, it may be hypothesized that the use of CHX in the interface location of composite resin restorations will slow down the secondary caries process. Therefore, the aim of this study was to evaluate the role of MMP inhibitor (2% 
CHX) in the secondary caries wall lesion development and progression in different interface conditions, including both bonded and non-bonded conditions with several gap sizes.
5.2 Material and Methods
Ethical approval was granted by the local Ethics in Research Committee (School of Dentistry, Federal University of Pelotas- Pelotas, RS, Brazil) under protocol number 1.634.686.
Study design
This study, using a microcosm biofilm model, was carried out in two runs. Run 1 
investigated the effect of MMP-inhibitor (chlorhexidine 2%, CHX) in secondary caries development at the tooth-composite interface in small gaps. Run 2 investigated the effect of MMP-inhibitor in wider gaps, while also considering the possible 
influence of an adhesive present at the interface. Dentin discs were restored with 
different composite-interfaces as shown in figure 1. The dentin of the interfaces 
was either pre-treated with chlorhexidine 2% (=CHX +) or not (=CHX-). In the small gap samples, interfaces were made with gaps of 30, 60 or 90 µm. Interfaces with composite placed directly onto the dentin, either bonded (Adpter Single Bond 2; 3M ESPE, St Paul, USA; AdSB) or not bonded. In the wide gap samples, interfaces were made with gaps of 100 µm, with or without the presence of an adhesive on the 
composite side (ClearFil SE Bond, Kuraray, Japan; CSE). Interfaces with composite placed directly to the dentin were also either bonded (CSE) or not bonded.
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Figure 1. Study design / interface conditions per run. All groups n=10. Run 1 – small gap study using Adpter Single Bond (AdSB) for bonded interface. Run 2 – wide gap study using ClearFil SE Bond (CSE) for bonded interface and 100 µm+B group.
Sample preparation and restorative procedures
Sample preparation and restorative procedures are shown in figure 2. Enamel-dentin discs were cut from bovine incisors using a water-cooled trephine drill. The enamel was removed by wet polishing with 80-grit SiC abrasive paper. To standardize the smear layer of the dentin, samples were wet polished with 600-grit SiC paper for 1 min. The dentin discs were sectioned which resulted in two halves 
that were restored with resin composite (Filtek Z250 XT, 3M, ESPE, St. Paul, USA).The bottom (pulpal) and interfacial side of the dentin hemi-sections assigned to small gap study (run 1) were etched with 35% phosphoric acid gel (15 s, Ultra-
Etch®, Ultradent Products. Inc., South Jordan, USA) and rinsed with water. When 
samples were allocated to pre-treatment with CHX, chlorhexidine 2% was applied 
after the etching on the interfacial wall. After 60 s, the excess of CHX-solution was removed with paper towels. Samples assigned to the bonding group (B), received an adhesive procedure (AdSB). Subsequently all halves (n=10 per group) were inserted in an acrylic mold (2.5 mm thickness and 6 mm diameter), restored with composite resin and polymerized (20 s), resulting in a round specimen: half dentin and half 
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composite with an overall layer of 1 mm layer of composite. At the interfacial wall either no matrix was used (NB group) or a metal matrix with standard width (2.0 mm) and different thicknesses (30, 60, 90 µm) was placed against this wall during composite placement, creating an intentional gap.Samples assigned to wide gaps study (run 2) were pre-treated with 2% CHX-solution (60 s) after acid primer application (CSE) on pulpal and interfacial side of dentin hemi-sections. B and NB groups were restored as in run 1, only now using CSE bonding agent. During restorative procedure, a metal matrix was placed against the dentin wall to create an intentional gap of 100 µm. Bonding agent was applied on the metal matrix to create the group with adhesive located at the side of resin composite (100 µm + B) .After the restorative procedures, the samples were covered with nail varnish except a central square window (2.0 x 2.0 mm) on top of the sample, incorporating 
the gap area. The gaps of the samples were measured with a WF10X lens (Future-
Tech Corp., Tokyo, Japan) coupled to a Microhardness tester (FM 700, Future-Tech 
Corp., Tokyo, Japan) at three different locations: 200 µm from each edge and in the middle of the gap (1000 µm from edge).
 Inactivation of antimicrobial effect of 2% CHX
All samples treated with 2 % CHX solution were immersed in a neutralizing solution (D/E Neutralizing Broth, Acumedia, Michigan, USA) before sterilization and 
biofilm formation procedures, in order to avoid a direct effect of the antimicrobial 
properties from CHX solution on biofilm growth. Samples treated with CHX were placed in a 2ml of neutralizing solution and homogenized for 10s. This process was repeated twice and subsequently the samples were cleaned with 2 ml of saline 
solution by homogenization (10s). The group that was not treated with CHX was subjected to the same protocol using distilled water instead of neutralizing solution.
Sterilization of samplesAll samples were sterilized by gamma radiation in the Regional Center of Oncology/Radiotherapy Service (Faculty of Medicine, Pelotas-RS, Brazil). The samples were kept moist in distilled water and placed at 2 cm from the radiation source. They were sterilized with gamma radiation from a cobalt-60 source using particle energies of 
1.25 MeV and submitted to 609.25 Gy/min. Total dose was 4.08 KGy.
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Figure 2. Sample preparation, gap measurement and T-WIM areas of analysis. A- Dentin discs were cut and two halves were obtained. B- Etching with phosphoric acid or primer acid was performed in the pulp and interfacial walls of all samples. C- MMP inhibitor was applied on the interfacial etched area in allocated groups. Bonding was applied on the pulpal wall of all 
samples and also on the interfacial wall of the samples assigned to bonding group. D- Halves with interfacial dentin wall pre-treated or not pre-treated with MMP inhibitor were placed in the resin composite layer. E- Final restorative procedures. Note the presence of metal matrix for 30, 60, 90, and 100 µm groups and no matrix for bonded and no-bonded groups. Bonding agent was applied on the metal matrix to create the group with adhesive on the composite side. F - Locations of gap measurement (a and c = 200 µm from each edge, and b = 1000 µm from edge – middle position). Dash lines represent the section that was used for T-WIM (1mm). G - Section cut from the dentin-resin composite sample and the locations of T-WIM measurements (1, 2, 3 and Sound Dentin: SD).
Microcosm biofilm modelEach run was carried out independently. Samples were submitted to cariogenic 
challenge using a microcosm biofilm model previously described elsewhere [Maske 
et al., 2015; Montagner et al., 2016]. Fresh whole saliva stimulated by paraffin film chewing was collected from a healthy volunteer (male, 24 years) who had not been 
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under antibiotic therapy for at least six months and abstained from oral hygiene for 24 h and from food ingestion for 2 h prior to collection. A 0.4 ml volume of saliva was inoculated onto each sample placed in a 24-microwell plate. The saliva remained at 
rest for 1 h at 37°C. Subsequently, 1.8 mL of defined medium enriched with mucin (DMM) [Wong and Sissions, 2001] containing 1% sucrose was added, and the plates were incubated at 37°C under an anaerobic atmosphere (5–10% CO2, less than 1% O2). After 6 h, the samples were rinsed with sterile saline (2 ml), inserted into a new plate containing DMM without sucrose, and incubated for more 18 h under the 
same conditions. The biofilms were formed individually on the resin-composite discs and in each well for 14 days. The same daily routine of alternate exposure to DMM supplemented with and without sucrose was followed (DMM+s and DMM, respectively).
Biofilm supernatant pH analysis
After the medium replacements, in both runs, biofilm supernatant pH readings 
were carried out in the DMM+S and DMM mediums used. The pH was individually and randomly recorded from each three wells per interface condition treated or not 
with MMP inhibitor (Quimis 50w - Quimis Aparelhos Científicos Ltda, Diadema, SP, 
Brazil; V621 electrode – Analion, Ribeirão Preto, SP, Brazil).
Microbiological controlTotal microorganisms counts were performed considering the groups treated or 
not treated with 2% CHX to confirm that pre-treatment had not affected biofilm development. On the 14th day of each independent run, the dentin-composite discs (n = 3 / interface condition) were removed from the wells and washed with sterile 
saline. The biofilm was then collected from the surface of each disc (including the gap surface) with a sterile microbrush and disposed in pre-weighed sterile tubes. 
The biofilms were dispersed by vortexing, sonicated for 30s (20 w), serially diluted (10-1-10-7) in saline solution, and inoculated in duplicate in the Brain Heart Infusion agar (Acumedia, Michigan, USA). The plates were incubated under anaerobic conditions for 96 h. The number of CFUs was determined by a blinded and trained 
researcher, and the results were expressed as CFUs/mg of biofilm (wet weight).
Transversal Wavelength Independent Microradiography (T-WIM)Secondary caries lesion development was evaluated using T-WIM. A 1 mm section was cut from each sample through the interface. Microradiographs of the sections 
113
MMP inhibitor and in vitro secondary caries
were taken with an exposure time of 12s and settings of 40kV and 20 mA. A step 
wedge with the same absorption coefficient as the dentin (94% Al / 6% Zn alloy) 
was used for proper quantitative measurement of lesion depth (LD, μm) and mineral 
loss (ML, μm.vol%). After X-ray exposure, the films were developed (10 min), fixed (7 min), rinsed (30 min) and dried. A digital image of each sample was captured using a 
light microscope (Leica Microsystems, Wetzlar, Germany) with a magnification of 11 
X and a CMOS camera (Canon EOS 50D, Tokyo, Japan). Lesion depth (LD) and mineral loss (ML) for T-WIM were measured with a software program (TWIM calculation 
program, version 5.25, J.de Vries, Groningen, NL) at three locations: surface lesion 
(400 μm distance from interface), and wall lesions at 200 and 500 μm distance from the entrance of the gap. As a control, LD and ML values were also determined from 
the sound surface at 400 μm distance from surface lesion (figure 2G).
Statistical AnalysisThe effect of pre-treatment with MMP inhibitor and interface conditions on caries outcomes (mineral loss and lesion depth) at wall lesion locations were analyzed using linear regression models per run. Data from total microorganisms (log10) 
counts and pH readings were analyzed using Two-Way ANOVA and Tukey post 
hoc test. All tests were conducted using the statistical software package SPSS (Statistical Package for Social Sciences, version 20.0, Chicago, IL, USA) and the 
statistical significance was set at p < 0.05.
5.3 Results
Run 1- Small gap sizeActual average gap sizes were: CHX+: NB = 13.4 µm (±0.39), 30 μm = 36.2 μm (±1.57), 
60 μm = 63.3 μm (±0.74), 90 μm = 93.8 μm (±2.89); and CHX-: NB = 13.7 µm (±0.91), 
30 μm = 33.3 μm (±1.39), 60 μm = 62.0 μm (±0.98), 90 μm = 93.1 μm (±0.85).The average values for LD and ML for each treatment, gap condition and location 
are shown in Figure 3. The dash line in this figure is a reference for LD and ML average values measured in sound dentin. Surface lesions showed highest ML and LD values. Dentin wall lesions were lower, with substantial lesion formation only in the intentional gaps at 200 µm from the surface.Results from the linear regression analyses are shown in Table 1. The pre-
treatment with MMP inhibitor did not influence the wall lesion progression at 
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either location (p ≥ 0.218). A gap of 60 and 90 µm significantly increased the lesion progression at 200 µm from the gap entrance (p < 0.001), but not at 500 µm distance.
Total microorganism and pH data are shown in Table 2. The final pH of DMM+S and DMM medium was 4.6 ± 0.04 and 7.1± 0.01, respectively. MMP inhibitor did not 
significantly affect pH readings and total microorganism counts (p ≥ 0.171), nor 
did interface condition (p ≥ 0.152). No significant interactions between the factors evaluated were observed.
Figure 3. Run 1: bar charts of a) lesion depth (LD; µm) and b) mineral loss (ML; µm.vol%) for each interface condition, pre-treatment and location of analysis. All groups n=10. The average value for sound surfaces is presented in the charts as a dash line.
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Run 2- wide gap sizeActual average gap sizes were: CHX+: NB = 12.3 µm (±0.47), 100 μm = 104.2 μm 
(±0.53), 100 μm+B = 102.4 μm (±1.47); and CHX-: NB = 13.7 µm (±0.66), 100 μm = 
102.8 μm (±0.85), and 100 μm+B = 107.0 μm (±1.81).LD and ML results for all groups are shown in Figure 4, showing a similar trend to that seen in Figure 3.
Figure 4. Run 2: bar charts of a) lesion depth (LD; µm) and b) mineral loss (ML; µm.vol%) considering each interface condition, pre-treatment performed, and areas of analysis. All groups n=10. The average value for sound surfaces is presented in the chart as a dash line.
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The linear regression results are also shown in Table 1. The pre-treatment with 
MMP inhibitor did not affect the wall lesion progression at either location (p ≥ 
0.302). Interfaces with gaps showed positive and significant effect on the wall lesion 
progression at 200 µm distance from the gap entrance (p ≤ 0.005). A small trend for the presence of bonding on the composite to increase wall lesion development at the 200 µm location could be observed, but overlapping 95% CIs show that this 
was not significant.
Pre-treatment and interface condition did not affect the pH readings (DMM and DMM+S) and the microbiological counts (p > 0.05). The factors evaluated did not 
show significant interactions (Table 2).
5.4 Discussion
In this study it was shown that the application of MMP inhibitor (2% CHX) did not reduce secondary caries development in dentin in small or wider gaps. As MMPs are thought to be involved in dentin caries progression and collagen degradation [Tjaderhane et al., 2013; Mazzoni et al., 2015] we expected that the application of 
MMPs inhibitor (2% CHX solution) on the dentin would reduce secondary caries 
lesion progression. However, this hypothesis could not be confirmed.
It has been demonstrated that CHX used as MMP inhibitor in demineralized dentin after etching and prior adhesive procedures improves the hybrid layer integrity and bond strength between tooth and composite resin [Carrilho et al., 
2007b; Montagner et al., 2015], but these results have not been confirmed in recent clinical trials [Gostemeyer and Schwendicke, 2016; Favetti et al., 2017]. It 
is speculated that MMPs remain inhibited for as long as CHX remains bonded to 
collagenous matrix, but there is still no consensus about how long a CHX solution will retain its MMP inhibitory activity in a dentin substrate [Carrilho et al., 2007b]. The 
mechanism by which CHX binds to demineralized dentin seems to be by electrostatic 
process [Kim et al., 2010]. Thus, as a covalent and strong bonding doesn’t occur 
between CHX and demineralized substrate, it is likely that the CHX leaches from the hybrid layer, reducing the inhibition of collagen degradation [Pashley et al., 2011].When a good restoration is made (i.e., without marginal defects), it is likely 
that CHX-saturated demineralized matrix becomes sequestered by adhesive resin 
coating collagen fibrils, and covered by an overlying adhesive layer, which may 
produce prolonged retention of CHX and inhibition of MMPs [Carrilho et al., 2007b]. 
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When marginal defects are present along the interface of the restoration, leaching 
of CHX could be facilitated, and its inhibiting effect compromised. In all simulated interfaces (small and wide gaps), except for the bonded groups, no adhesive barrier covering the dentin substrate was reproduced in this study. This lack of barrier 
may have led to an accelerated leaching of CHX from the demineralized dentin, 
which would explain the lack of caries-reducing effect. . However, CHX retention was not evaluated on dentin interface condition and future analyses are still needed 
to confirm the findings.Unlike other studies evaluating the effect of MMPs inhibitors as treatment in dentin substrate [Nishitani et al., 2006; Magalhaes et al., 2009; Almahdy et al., 
2015], all samples in this study were sterilized by gamma radiation (4.08 KGy) after restorative procedures. This sterilization method was used to avoid external 
contamination in the biofilm model used. This might raise some concerns about the presence of MMP activity in our samples once a high dose-radiation could 
inactivate the proteases in the substrate. However, gamma radiation is reported to be a suitable sterilization method of biological/ bioactive products or tissues, 
maintaining ~ 90% of proteases activity when doses between 0-10 KGy where applied. Bioactivity of collagen type I is preserved after sterilization with total 
dose up to 20 KGy [Furuta et al., 2002; Wiegand et al., 2009; Dyankova et al., 2014]. Also the integrity of MMP-2 and -9 and their pro-and active forms were maintained 
in bovine dentin substrate even after using a high dose of gamma radiation (25 KGy) 
[Kellen Gasque [2011]. In addition, we recently observed that gamma sterilized dentin substrate showed collagen type I degradation after cariogenic challenge 
produced by the same biofilm model used in the present study [Maske et al., 2015]. 
This means that MMP activity was still present even after radiation with 4.08 KGy. 
Considering these findings, the authors do not believe that the sterilization method 
used could interfere in MMPs activity and therefore influence the results found in 
the present study. However, we recognize that MMP activity on sound substrate was 
not evaluated in dentin substrate used and more studies are still needed to confirm 
the findings presented here.The results of this study showed that secondary wall lesions can develop in gaps larger than 30 µm (34. 6 ±4.0µm) and as small as 60 µm (62.6 ±0.84). Although LD and ML values were measured for gaps lower than 30 µm (NB= 13.58±0.75 µm), it is important to point out that these are not to be interpreted as secondary caries wall lesion, as they are similar to values measured in sound surfaces. This means 
that the gap threshold for wall lesion development in the current biofilm model 
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seems to be around 30 µm. In a recent study with gaps not pre-treated with CHX the results were essentially the same [Maske et al., 2017].The secondary caries wall lesion progression showed a slight trend to increment 
when bonding material was present on the resin composite at first wall location evaluated (Run 2). The presence of bonding material may act as a retention factor for 
biofilm growth and this could explain the increase of secondary caries progression in this condition. Results from a recent in situ study performed by our group support 
the present finding [Montagner et al., 2015].
This was the first study trying to show the role of MMP inhibitor on secondary lesion development and limitations need to be pointed out. 1) Sound instead of 
caries-affected dentin substrate was used and maybe the effect of CHX would have been clearer when some MMPs had already been activated by the dental caries process. 2) Bonded and non-bonded conditions with several gap sizes were simulated; however other conditions possibly including aged interfaces should be tested. 3) MMPs may also be present in the oral environment from other origins 
such as gingival crevicular fluid and from salivary glands [Chaussain-Miller et al., 2006] and these could have a role in secondary caries development. The present model could not include these MMP sources, and in situ and/or clinical studies may be needed to assess their role.
5.5 Conclusion
The dentin pre-treatment with MMP inhibitor (CHX 2%) was not able to slow down 
the secondary caries wall lesion development in small and wide gaps in this biofilm model.
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Secondary caries development and the role of a 
matrix metalloproteinase inhibitor: a clinical in 
situ study
This chapter was published as: Maske TT, Kuper NK, Hollanders ACC, Bronkhorst EM, 
Cenci MS, Huysmans, MCDNJM (2018). Secondary caries development and the role of a 
matrix metalloproteinase inhibitor: a clinical in situ study. Journal of Dentistry 71:49-
53.
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Abstract
Objectives: This in situ study aimed to investigate whether the dentin treatment 
with MMPs inhibitor (CHX 2%) could influence the development of secondary caries wall lesions in different dentin-composite interfaces.
Material and Methods: For 21 days, 15 volunteers wore a modified-occlusal 
splint loaded with dentin-composite samples treated or not with CHX and restored according 4 different interface conditions: Bonding (B = samples restored with complete adhesive procedure), no bonding (NB = restored with composite resin without adhesive procedure), 100 µm (no adhesive procedure and with intentional gap) and 100 µm + B (adhesive material on composite side and intentional gap). Eight times per day, the splint with samples was dipped in a 20% sucrose solution for 10 minutes. Before and after caries development, samples were imaged with T-WIM and lesion depth (LD) and mineral loss (ML) were calculated.
Results: Linear mixed effect analysis showed that dentin treatment with CHX did 
not significantly affect the caries lesion progression (LD and ML; p ≥ 0.261). Dentin wall lesions were observed in the 100 µm and 100 µm+B groups independently of MMP inhibitor treatment.
Conclusion: The treatment of dentin with MMP inhibitor was not able to slow down the secondary caries wall lesion development in this in situ study.
Significance: The dentin treatment with 2% CHX did not prevent secondary caries wall lesion initiation.
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6.1 IntroductionD ental work in general practice consists of a significant proportion of placing and replacing restorations. Secondary caries has been shown to be the most common reason for posterior restoration failure (Demarco et al., 2012; Mjor et al., 2000; Opdam et al., 2014).Over time, dynamics in the oral cavity, e.g. masticatory forces, enzymatic activity 
of dentin (proteinases), and biofilm activity may negatively affect the quality of the restoration interface leading to marginal gaps or defects. In the presence of cariogenic plaque and fermentation products this can result in secondary caries development (Carvalho and Manso, 2016). Therefore, the good sealing between dentin and restorative material is the main focus to prevent secondary caries and to prolong the lifetime of composite restorations (Nedeljkovic et al., 2015).Several studies have shown that enzymatic activity in dentin contributes 
significantly to adhesive interface degradation (Carvalho and Manso, 2016; Tjaderhane et al., 2013a; Tjaderhane et al., 2013b). This phenomenon can be attributed to host-derived enzymes such as Matrix Metalloproteinases (MMPs) which are Zn+2 - and Ca+2 -dependent endopeptidases and are considered to be mainly responsible for degrading collagenous dentin proteins(Mazzoni et al., 2015; Visse and Nagase, 2003) . The MMPs are also claimed to be involved during progression of dentin caries lesions, where they are responsible for breakdown of the collagenous organic matrix of dentin after demineralization occasioned by acid from bacteria metabolism (Mazzoni et al., 2015; Takahashi and Nyvad, 2016).The activity of MMPs on dentin substrate can be retarded by use of inhibitors. Several studies have demonstrated increase of bonding strength and reduced interfacial degradation over time when MMP inhibitors are used during adhesive 
procedure (e.g., chlorhexidine – CHX, galardin, hesperidin, etc.) (Breschi et al., 2010; Montagner et al., 2014). Recently, exogenous MMPs inhibitors were reported to reduce the degradation of human dentin matrix (acid-demineralized dentin) in situ (van Strijp et al., 2015) and retard the caries process in rats (Sulkala et al., 2001). Similarly, other in situ studies have been showing that gels or solutions delivering 
MMPs inhibitions including CHX are able to prevent dental demineralization caused 
by erosion (Kato et al., 2010; Magalhaes et al., 2009). These observations suggest that approaches against organic matrix degradation might also be useful in caries prevention (Takahashi and Nyvad, 2016; Tjaderhane et al., 2015).
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A number of studies have investigated the effect of CHX as MMP inhibitor on bonding stability when there is a good marginal seal (Breschi et al., 2009; Carrilho 
et al., 2007a; Komori et al., 2009). To the authors’ knowledge there are no previous studies evaluating the effect of this MMP inhibitor on secondary caries development at interfaces with a compromised marginal seal due to defects at the interface (e.g. gaps). Therefore, the aim of this in situ study was to investigate whether the 
dentin treatment with MMP inhibitor (CHX 2%) could influence the development of secondary caries wall lesions in different interfaces, including bonded and non-bonded conditions and interfacial gaps. The hypothesis of this study was that MMP inhibitor would reduce secondary caries wall lesion progression.
6.2 Material and Methods
Study designThis was a mono-centre in situ study with a split mouth design. The protocol and design of this study were submitted and approved by an Ethical Committee Board (CMO code NL 56622.091.16). Independent variables were dentin treatment applied 
or not (2% CHX, MMP inhibitor) and interface conditions whereas the outcome variables were mineral loss (ML) and lesion depth (LD).
Sample size calculationSince a split mouth design would be used, the equation for sample size calculation 
was applied: n= f(α,β)*σ2/(µ1-µ2)2 (Pandis, 2012). Using a power of 90%, significance 
level of 5% and considering the outcomes from a previously published study (Kuper et al., 2014), the following parameters were used: the average between the SD from 
no gap and smallest gap size (σ =26.5); average of lesion progression in dentin samples restored with composite and with wall lesion development (µ1= 48.5 µm); and difference on lesion progression lower than 50%, which would not be clinically meaningful (µ2= 24.3 µm). The sample size needed was 13 volunteers. Considering 
a drop-out rate of 20%, the final sample required was 16 volunteers.
VolunteersSixteen volunteers with good general health (5 men and 11 women, mean age = 28.4 years) were recruited within the Campus of Radboud University (Nijmegen, The Netherlands). All the volunteers agreed and signed the written informed consent. 
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Exclusion criteria were active caries, periodontitis (DPSI > 2), ASA > 2, and the wearing of orthodontic or a removable prosthetic appliance in the mandibular jaw.
Sample preparation
Thirty-two sound human molars were collected and ground flat with 220-grit Sic paper until complete enamel removal and dentin exposure. The roots were cut off with a diamond blade (Buehler diamond wafering blade nr.11-4244) and the 
remaining crowns were perpendicularly cut in 64 dentin bars with fixed width of 3.2 mm and various lengths. Subsequently the dentin bars were manually ground 
with 400-grit Sic paper to a height of 2.0 mm (figure 1A-B) and sterilized with 
ethylene oxide (Isotron Nederland B.V., Venlo, The Netherlands) (Kuper et al., 2014). One dentin-composite sample was created by two dentin bars that were attached 
to each other with a thin layer of composite (0.5mm) fixed with self-etching primer 
and bonding agent on the pulpal side (ClearFil SE Bond, Kuraray, Okayama, Japan; 
CSE) (figure 1C). In each dentin-composite sample, four slots were made parallel to the dentin tubule with a 0.12 cylindrical bur with a depth of 1.9mm.Self-etching 
primer was applied on the dentin wall of each produced slot. Subsequently, 2% CHX solution was applied with a disposable syringe for 60 s on dentin samples assigned 
to pre-treatment (figure 1D-F).
 Two slots were filled with resin composite (AP-X PLT, color A2, Clearfil, Kuraray, 
Okayama, Japan) and a gap was created by placing a matrix of 100 µm of thickness between the dentin and the composite. One of these slots received a layer of bonding material on side of metal matrix creating an interface where bonding was located on resin composite side of the gap (100 µm+B). From the remaining two slots, one 
was filled completely with composite, but no adhesive was used (no bonding; NB) and the other slot was restored with composite and adhesive procedure (Bonding; 
B - control group; CSE) (figure 1G). Resin composite and bonding agents were 
activated according to manufactures’ instructions using a Bluephase® 20i light curing (Ivoclar Vivadent Ltda). Those dentin-composite samples treated with MMP inhibitor were immersed in 2 ml of neutralizing solution (2 x; D/E Neutralizing Broth, Acumedia, Michigan, USA) for 10s and followed by immersion in distilled water (10 s) to inactivate the antibacterial effect of MMP inhibition solution used and therefore to avoid crossed effects in the study. The same protocol was used to dentin-composite samples not treated with MMP inhibitor, but distilled water was used instead of neutralizing solution.
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 Each volunteer received a modified-occlusal splint for mandibular jaw (figure 
1H) with buccal flanges holding four embedded metal slots of 20 mm x 3.2 mm x 2.5 mm. Only the two upper slots were used for this study. Thirty-two dentin-composite samples were placed at left or right side alternately per volunteer considering the treatment applied (n=16 / treatment). Positions of different composite-dentin interface conditions (B, NB, 100 µm and 100 µm+B) were changed per volunteer (mesial to distal). The sequence was manually generated using computer software (Excel Program).
Figure 1. Sample preparation and experimental design: A) 1- Complete enamel removal and dentin exposure. 2- Roots were cut off. 3- Dentin bars were made by cutting. B) Dentin bars (2mm thickness and 3.2 mm width). C) Dentin-resin composite bars: two dentin bars were attached to each other by a resin composite (RC) layer. D) Four slots were made in the 
dentin-composite bars. E) Primer acid was applied at all dentin walls. F) CHX solution was applied at the dentin wall of samples assigned to pre-treatment. G) Each slot was restored 
with resin composite according to interface condition. Those samples treated with CHX were 
immersed in neutralizing solution. H) Modified-occlusal splint loaded with dentin-composite samples: bonding (B), no bonding (NB), 100 µm+B, and 100µm. Samples were placed at left and right side alternately per volunteer considering the treatment applied. T-WIM images were made before and after experimental run (21 days) and true lesion depth (LD) and mineral loss (ML) were calculated.
Experimental protocolThe occlusal splints were worn 24 h per day for 21 days (3 weeks), and were only removed during eating, drinking or oral hygiene. During these periods the device remained in physiological salt solution. Volunteers were instructed to dip the splint 
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in 20% sucrose solution eight times per day (10 min). The intervals between sucrose dippings were at least 1h. They received a diary to record the exact moments of sucrose exposure. After the dipping in sucrose, the splint was rinsed with tap 
water and replaced in the mouth. All volunteers used fluoride toothpaste (1450 ppm; Colgate Caries Protection, Colgate-Palmolive-Company, The Netherlands) and 
were asked to apply the fluoride toothpaste slurry on the samples once a day (2 min) when they brushed their teeth. The volunteers were instructed not to clean or brush the samples. Instructions were given both orally and in writing by a researcher involved in the study.
Transversal wavelength independent microradiography (T-WIM)T-WIM images were made at baseline (T0) and after 21 days (T21). The microradiographs were taken using 45 kV, 40mA and 8s of x-ray exposure. A step 
wedge with the same absorption coefficient as tooth material (94% Al/6% Zn alloy) 
was used for quantitative measurement of LD and ML. After x-ray exposure, films 
were developed (10 min), fixed (7 min), rinsed and dried. Digital images of each sample were recorded with a light microscope (Leica Microsystems, Germany) with 
a magnification of ×10 and a CMOS camera (Canon EOS 50D, Japan). The T-WIM 
images were edited using the method of Kuper et al. (2014). From each sample the wall lesions in the dentin facing the gaps were measured using a software 
program developed in our laboratory at a fixed area 400 μm under the surface. Baseline measurements (T0) were subtracted from measurements taken after 21 days (T21), in order to estimate true LD and ML. The subtracted values were used in the statistical analysis. Actual gap sizes were measured on gaps from baseline 
T-WIM images using the same software program as described elsewhere (Kuper et al., 2014).
Statistical analysisThe effect of MMP inhibitor on LD and ML was analysed using linear mixed-effects models. Absolute differences between averages of LD and ML considering the effect 
of MMP inhibitor were entered into the model as fixed effect. More complex mixed-effects models were tested to verify the effect of added factors such as location of the gap (more distal or mesial) and interface conditions. The created models were compared among them by ANOVA. As there was not an improvement in the models by addition of factors (p > 0.05), a simple mixed-effect model was used. All tests 
were conducted using R statistical program with the significant level set as 5%.
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6.3 Results
Fifteen volunteers completed the study successfully in 21 days. One volunteer did not comply with the study protocol and wore the device for only 6 consecutive days during the trial running and was therefore excluded of data-analysis. Unfortunately, the enamel of four samples wasn’t completely removed during sample preparation. In total, four volunteers had samples excluded in three different interface conditions. 
Two volunteers had samples excluded from 100 µm group without CHX (-), another 
volunteer had one sample from 100 µm+B group with CHX (+) excluded, and one 
volunteer had one sample from 100 µm +B group with CHX (-) excluded.Of the samples with an intentional gap of about 100 µm, the actual gap size was 125.9 ± 24.24 µm.Descriptive values for LD (µm) and ML (µm.vol%) are shown in Figure 2. Dentin wall lesions were observed in intentional gaps (100 µm and 100 µm+B) independently of MMP inhibitor treatment applied. B and NB did not showed substantial secondary caries wall lesions.The linear mixed effect analysis showed that the effect of treatment with MMP inhibitor on LD was -1.89 µm (SE=7.31 and CI 95%= - 16.67 / 12.86), which is not 
significant (p=0.797). The effect of pretreatment with MMP inhibitor on ML was 
-138.0 µm.vol% (SE=121.4 and CI 95% = -373.3 / 107.2), which is also not significant (p=0.26). More complex mixed-effects models showed that factors such as gap 
location (more distal or mesial) and interface conditions did not influence the effect 
of treatment with MMP inhibitor (p ≥ 0.09).
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Figure 2. Bar charts showing the LD and ML average values for each group considering 
dentin treatment. Bars on the left side represent the application of pre-treatment (CHX+), 
and those on the right side represent not treatment (CHX-). The linear mixed effect analysis 
showed that the effect of treatment with MMP inhibitor on LD and ML was not significant (p > 0.26).
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6.4 Discussion
This study showed that dentin pre-treatment with MMP inhibitor (CHX 2%) did 
not influence secondary caries wall lesion development in any interface condition. Therefore, the hypothesis stated was rejected in this in situ study.
As it is ethically not justified to induce caries in humans intentionally and as it is technically not possible to assess the true outcome of the caries disease (e.g., mineral loss) in a clinical study (Askar et al., 2017), in situ studies seem to be ideal to investigate factors related to caries lesion development. These models optimize the balance between clinical relevance and control of key variables (Ferracane, 
2017). Recently our group investigated the effect of MMP inhibitor (CHX 2%) using 
an in vitro microcosm biofilm model (data not published yet), but interpersonal variations and oral cavity environment could not be considered in those results. The 
present study reflects therefore a more clinically relevant scenario to evaluate the role of dentin treatment with MMP inhibitor on secondary wall lesion progression in interfaces containing gaps.Four interface conditions were evaluated in this study. Secondary wall lesions only developed when there was an intentional gap at the restoration interface (100 µm and 100µm+B). Samples from B group (control) didn’t show any wall lesion. In NB group, a minimal gap size was simulated by bonding material omission, but ML 
and LD values showed the same results as in the control group (B). This confirms that a critical gap size (threshold) is needed for secondary wall lesion development 
(Kuper et al., 2014; Maske et al., 2017).The presence of bonding material on the composite side may act as a predisposing 
factor for biofilm retention at interface and an increase of wall lesion progression was recently observed by Montagner et al. (2015), but a similar behaviour was not observed in the present study. The differences in gap sizes used in each study could 
explain the conflicting results. Wider gaps (~200µm) with bonding material on 
composite side may favour the retention of more biofilm at interface than smaller gaps (~100 µm).
The dentin treatment with MMP inhibitor had a minimal and not significant estimated effect of slowing down wall lesion progression (-1.89 µm to LD and -138.0 
µm.vol% to ML). A possible hypothesis to the lack of effect of CHX treatment in this study may be related to the presence of defects at the interface (gaps). The theory 
behind this is that CHX might be leached from the interface. When an optimally 
bonded restoration is made (i.e., without marginal defects), it is likely that CHX-
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saturated demineralized matrix becomes sequestered by adhesive resin coating 
collagen fibrils which may produce prolonged CHX retention and inhibition of MMPs 
(Carrilho et al., 2007b). However, when marginal defects are present along the 
interface of the restoration, leaching of CHX could be facilitated, and its inhibiting effect compromised.
In vitro studies developed by Kim et al. (2011; 2012) have shown that 
demineralized dentin treated with 0.2 or 2% CHX and stored in a body fluid (6 weeks and without successive acid challenges) displayed collagen integrity and deposition 
of granular minerals along collagen fibrils when compared to the no CHX-treated. 
The present in situ study showed that demineralized dentin treated with 2% CHX was ineffective to slow down demineralization on tooth-resin-interfaces containing gaps. The former studies seem to be limited to mimic the oral cavity dynamics 
over 6 weeks storage time. The lack of pH-cycling episodes during the storage time 
(activating other latent MMPs in the substrate) could explain the conflicting results.Other in situ studies evaluating the use of MMP inhibitors in prevention of dentin demineralization have demonstrated a positive effect of this therapy. Sulkala et 
al. (2001) using non-antimicrobial chemically modified tetracyclines applied 5 
times per day (during 7 weeks) showed a reduction of fissure caries progression. 
Magalhaes et al. ( 2009) and Hannas et al. (2016) demonstrated that green tea and 
CHX applied either 2x (by toothpaste) or 4x (by solution) per day during 5 days were also able to prevent demineralization by erosion. These positive effects on slowing down dentin demineralization could be related to frequent availability of the MMP inhibitor (used more than once per day) in the area prone to demineralization. The use of other vehicles as gels to deliver MMP inhibitor compounds could also increase 
the contact time with dentin and enhance substantivity of the product (Kato et al., 
2010). In this in situ study 2% CHX was used as solution and only applied once as pre-restoration treatment protocol and therefore it could explain the lack of effect in slowing down caries lesion.
To knowledge of the authors, this study is the first to show the role of MMP inhibitor on secondary lesion development in a more clinically relevant scenario and limitations need to be highlighted. A sound substrate was used instead of 
caries-affected dentin and maybe the effect of CHX would have been clearer when collagen matrix had already been exposed by the dental caries process and some MMPs had already been activated. Moreover, in a clinical situation adhesive interfaces may degrade creating failed bonded interface conditions (Montagner et al., 2015; Montagner et al., 2016). The role of MMP inhibitor on secondary caries 
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lesion considering such failed-interfaces could bring interesting findings. These 
suppositions should still be confirmed in further studies.
6.5 Conclusion
Within the limits of this in situ study the pre-treatment of dentin with MMP inhibitor was not able to reduce secondary caries wall lesion development.
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7.1 General discussionA s previously discussed we know that certain factors have already been related to secondary caries lesion development and other factors such as threshold gap size, caries risk and dentin enzymatic degradation still needed to be researched. 
These factors and other relevant findings will be discussed in the following sections considering the results found in the present PhD research.
7.1.1 In vitro and in situ biofilm models - study designThrough the systematic review presented in the Chapter 2 it was concluded that 
few biofilm models showed dose-response validation to anti-caries or antimicrobial 
substances and reproducibility. Validation of in vitro biofilm models is important to 
confirm that they reflect clinical reality with similar sensitivity and reproducibility of response found in the oral cavity.
Microcosm-based biofilm models seem to be closer to natural dental biofilm (McBain, 2009). Using an inoculum source based on saliva or dental plaque thousands of different strains may compete or collaborate with each other to establish a microbial community. As dental caries is a result of metabolic interactions of a diverse microbial community, this source seems to be the best to 
simulate the complexity of biofilm-caries process (Sissons, 1997). In the present 
thesis two kinds of biofilm models were used (in vitro and in situ). Chapter 3 and 
5 used a microcosm laboratorial model dose-responsive to CHX (0 - 0.12%) and with a pattern of reproducibility against this antimicrobial solution (van de Sande et al., 2011). Chapter 4 and 6 showed studies in a standardized in situ model to 
investigate secondary caries lesions (Kuper et al., 2014; Kuper et al., 2015a; Montagner et al., 2015). In situ studies have been considered the bridge between the natural uncontrolled clinical situation and the highly controlled laboratory situation. These models aim to mimic what occurs in the natural caries process and provide clinically relevant information in a relatively short period of time without damage to the natural dentition (Zero, 1995).According to Maltz and Beighton (2012) studies focusing on caries lesion 
progression should be tested first in the best available laboratorial model and subsequently tested in situ or in a clinical situation to build the evidence base in a progressive scale of complexity. Studies presented in Section 1 (small gap size) and Section 2 (MMP inhibitor) tried to construct the evidence in a progressive 
complexity of biofilm models.
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It is worth mentioning that independent of in vitro or in situ biofilm models used 
(Chapters 3-6) the studies showed similar and consistent results. For example, wall lesions developed in gaps of around 30 µm in both in vitro and in situ studies, even though in situ studies showed wide interpersonal variation in the extent of the lesions. In addition, secondary caries lesion development after dentin pre-treatment 
with 2% CHX solution or without such pre-treatment was also essentially the same in both models.
The above-mentioned findings highlight that the use of a validated in vitro model with high complexity (microcosms) could bring relevant evidence before in situ 
tests. It is particularly important to economize scientific work and to not expose volunteers to test situation without necessity.
7.1.2 Marginal defect and gap sizesThe cause of tooth demineralization around restorations has been attributed to leakage of bacteria or their acid products into the gap formed in the tooth-material interface (Carvalho and Manso, 2016; Ferracane, 2017).Even using acid etching and bonding agent during restorative procedure to produce the best feasible interface condition, an unavoidable gap of 6-10 µm may be found at the tooth-restoration interface (Irie et al., 2002). Results from in vitro and in situ studies carried out in Chapters 3 – 6 showed that no secondary caries wall lesions developed in this condition, implying that gaps wider than 10 µm are needed to allow for secondary caries wall lesions development. Chapters 3 and 4 also showed that samples restored with omission of bonding material, resulting in a gap of about 13 µm, did not develop secondary caries wall lesions either. Wall lesion development was only observed when gap size of around 30 µm was present. We therefore concluded that the threshold gap size for wall lesion development 
lies somewhere between 13 and 30 µm. These findings are in agreement with 
Khvostenko et al. (2015) who showed biofilm colonization in similar gaps (~15 
and ~30 µm). In addition, Derand et al. (1991) using a monoculture biofilm model observed that secondary caries lesions around amalgam restorations occurred 
when a gap size of 30 µm or more (40, 60 and 80 µm) and a thick biofilm covering the restoration margin were present. In Chapter 6 (in situ study), secondary caries 
progression occurred in gaps wider than 27.5 µm in most of the volunteers. However, we also observed that in two volunteers no secondary caries lesions developed in any gaps, including the widest gaps of about 100 µm. This may point towards an 
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important role for individual protective or risk factors and this will be addressed later on.Totiam et al. (2007) compared secondary lesion development in several gaps (25, 250 and 1000 µm) in an vitro study and concluded that the gap size affected lesion progression along the cavity wall, with a trend for deeper lesions associated with 
bigger gap sizes. Kuper et al. (2015) also showed increased wall lesion progression with wider gaps. Findings from our in vitro study (Chapter 3), however, did not demonstrate the same trend. The gap sizes we used have a relatively small variation 
in size between tested groups and this could be the reason we did not find a trend. In Chapter 5, 60 and 90 µm gap sizes also showed essentially the same lesion progression (independent of MMP treatment applied).
Section 1 showed that secondary caries wall and outer lesions had a different progression depending on the study design used. In an in situ condition, wall lesions were bigger than surface lesions and in the in vitro condition it was other way around (see table 1).
Table 1. Secondary caries lesions in in vitro (Chapter 3) and in situ (Chapter 4) studies from Section 1
Study and condition (examples) Lesion Depth (µm)
surface lesion
Lesion Depth (µm)
wall lesionChapter 3 – 90 µm* 130.3 (13.8) 105.7 (34.9)Chapter 4 – 90 µm* 43.7 ± 32.3 82.3 ± 69.4*average of group
This may be explained by different condition for biofilm development. In Chapter 
3 the biofilm was statically formed on dentin samples / gap entrance without the complex dynamic of oral cavity that occurs in the in situ model such as presence of 
salivary flow and tongue movements. The biofilm accumulation on top of the in vitro samples without external disturbances is likely to result in deeper surface lesions.Moreover, in both in vitro studies considering small gap sizes (Chapter 3 and 
5) we observed that wall lesions in intentional gaps (30, 60 and 90 µm) were formed in the location closest to the surface (200 µm from the gap entrance). It 
could be also explained by stagnation of biofilm on top of samples without external disturbances mainly related to occlusal loading. As there is no loading to improve 
biofilm colonization inside these very small gaps, the lesions formed were more 
superficial (Khvostenko et al., 2015).
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7.1.3 Caries riskDental caries is a complex multifactorial disease. It is known that caries is a 
biofilm-sugar-dependent pathology with other factors, such as salivary function 
and composition acting in its progression (Hicks et al., 2003; Marsh, 2006; Selwitz et al., 2007).In our in situ studies (Chapter 4 and 6) we controlled two oral factors related to caries risk progression: oral hygiene and cariogenic diet. Volunteers were asked to not brush the samples inside the device since this is one of the most important factors to develop caries lesion. Moreover, all volunteers dipped their samples 8 x per day in sucrose solution to mimic a highly cariogenic diet. Although all volunteers were exposed to the same cariogenic condition, widely different patterns of secondary caries lesion development were observed (from no lesion development 
at all to significant lesion development). These findings indicate that patients’ caries 
activity is not only influenced by oral hygiene and diet, but that other individual 
intra-oral factors play a significant role (either protective or promoting). A possible explanation for why patients experiencing the same cariogenic challenge have such different caries progression may lie in genetic predisposition acting on factors such 
as biofilm composition and saliva composition (Bretz et al., 2003; Opal et al., 2015).In Chapter 4, we tried to link the level of secondary caries and a threshold gap size to the caries activity level (caries risk) of the volunteer. Thus, volunteers and their pattern of wall lesion depth progression in intentional gaps were grouped into three secondary caries activity levels (low, mid and high). It was observed that independent of caries activity level of the volunteers, the secondary caries wall lesions developed already in the smallest gaps present (> 27.5 µm). Possibly due to the limited number of volunteers we were not able to show a relation of gap threshold with caries risk. We did notice a trend for larger wall lesions in wider gaps for the high caries activity volunteers. It is worth pointing out that it could be related to caries activity level criteria used, but it could also be related to more 
biofilm accumulation in the space between tooth and restoration (Kuper et al., 2015; Totiam et al., 2007).
Clinically, the findings presented in Chapter 4 show that a dentist should 
consider their patients’ individual caries risk profiles when making treatment decisions regarding restorations with imperfect margins. Although marginal defects have been shown to be a factor in secondary lesion development (Diercke 
et al., 2009; Kuper et al., 2014; Totiam et al., 2007), focussing only on gaps may be 
an oversimplification.
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7.1.4 Tooth-material interfaceIn the general introduction it was discussed how dental materials located at the 
interface could influence secondary caries wall lesion in several ways, with a possible role for the type of dental material, failure mode and properties of the 
bonding (Kuper et al., 2015a; Kuper et al., 2015b; Montagner et al., 2015; Montagner et al., 2016; van de Sande et al., 2014). In the present thesis we evaluated three conditions of tooth-material interface: i) adhesive material present on interface to bond tooth and composite, ii) adhesive material omitted from interface and iii) adhesive located at the side of the composite on interface with gap.Interfaces conditions i (named bonding / bonded) and ii (no bonding / no-bonded) showed consistently the same results both in in vitro and in situ studies. Although ML and LD values were measured for these conditions in the studies, they did not 
reflect actual caries lesions and but should be considered an artefact of the T-WIM method (Thomas et al., 2006). As we never found caries wall lesion development in the restorations without intentional gaps, whether they were perfectly bonded or not bonded at all (independent of small gaps formed due shrinkage or incomplete polymerization), we may conclude that a tooth-restoration interface containing very small gaps up to about 13 µm are likely not susceptible to wall lesion development.Interface condition iii (named 100µm+B) was evaluated in Chapter 5 and 
6. This condition was already studied in situ by Montagner et al. (2015) using a gap size of around 200 µm. In that situation, the presence of bonding material on composite side increased secondary caries wall lesion progression. Both studies presented in this thesis (in situ and in vitro) showed a small trend to increase the lesion progression. The difference in the effect may be related to the difference in 
gap sizes. Wider gaps (~200 µm) could allow more biofilm accumulation than the smaller gaps (~100 µm) used in this thesis. The main conclusion that can be draw for this condition is that when, after failure, the adhesive is located at side of composite there may be a higher risk for wall lesion progression.
7.1.5 Dentin enzymatic degradation and Matrix metalloproteinases inhibitorIt is well established that matrix metalloproteinases (MMPs) play a central role in several biological and pathological process. MMPs have been claimed to play an important role in the dentin organic degradation following demineralization by bacterial acids and therefore in the control of the dentin caries process (Takahashi and Nyvad, 2016).
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During self-etching and etch-and-rinse adhesive procedures, after application of acid primer etching or phosphoric acid, the exposed collagen matrix is also vulnerable to degradation by MMPs (Mazzoni et al., 2006; Mazzoni et al., 2015). The enzymatic degradation of collagen by MMPs is reported as an important factor for destruction of the bonded interface (Montagner et al., 2014). The application of MMP inhibitor on dentin after acid etching improved the integrity and stability of tooth restoration over time (De Munck et al., 2010; Loguercio et al., 2009). The 
most used MMP inhibitor in adhesive procedures is chlorhexidine (CHX) applied in concentrations between 0.2% to 2% (Montagner et al., 2014; Tjaderhane et al., 2015).
Considering the pre-treatment of dentin with CHX during adhesive procedures in dental restorations and that this solution (MMP inhibitor) could act in the dentin caries control, the main goal of the Chapter 5 and 6 was evaluate the role of MMP inhibitor used during the adhesive procedure on prevention of secondary caries wall lesion progression.Both study designs (in vitro and in situ) used in the present thesis showed that 
2% CHX solution used as a dentin pre-treatment on tooth-restoration with gaps did 
not slow down the wall lesion progression. By these findings we can formulate some 
hypotheses: i) presence of a gap in the interface may help the CHX leaching from this space and therefore terming its effect as MMPs inhibitor, ii) to be effective the MMP inhibitor should be consistently present on interface to allow inactivation of 
new MMPs activated by pH cycling episodes.It is worth mentioning that a sound substrate was used instead of caries-affected 
dentin in both studies performed. Maybe the effect of CHX-MMP inhibitor would have been clearer when collagen matrix had already been exposed by the dental caries process and some MMPs had already been activated by this process. On the other hand, we tried to mimic the MMP activation using acid etching and acid primer before restorative procedures to therefore maximize the MMP inhibitor effect. Moreover, only bonded and no-bonded interfaces with gap sizes were simulated in our MMP inhibitor studies (Section 2). Other clinical conditions where adhesive could be degraded by ageing and creating failed bonded interfaces should also be tested.Although a theory behind MMP inhibitors and their effect on caries progression is well discussed in the literature (Buzalaf et al., 2015; Mazzoni et al., 2015; Takahashi and Nyvad, 2016; Tjaderhane et al., 2015) there are only few experimental studies focused on this topic. Sulkala et al. (2001) using a non-antimicrobial chemically 
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modified tetracyclines showed a reduction of dentin fissure caries progression when 
applied five times per day (during 7 weeks). Van Strijp et al. (2015) showed that hesperidin applied 2 x per day was able to decrease collagen degradation by 24% compared to control samples. It is worth mentioning that in that study hesperidin did not have its antimicrobial properties inactivated and therefore the effect found by authors could be in part related to an antimicrobial effect. On the other hand, 
Islam et al. (2012) using a pH cycling model (no microbial model) showed that hesperidin solution was able to slow down primary dentin caries progression and decreased collagen degradation.
In addition, Islam et al. (2012) also tested 0.2 % CHX solution as MMP inhibitor. 
TMR measurements showed that incubation in CHX (2h per day during 8 days) did 
not contribute to suppression of mineral loss. Moreover, findings from Hiraishi et 
al. (2011) also confirm this assumption showing that CHX did not show significant 
difference in root dentin lesion depth compared to positive control (no CHX pre-
treatment). Even using a simplified model to test caries progression, former studies 
confirm the results found in this thesis and reported in Chapter 5 and 6. The experimental literature about the role of MMP inhibitor on caries lesion 
progression thus does not present a consistent picture, with some positive findings 
and some negative (no effect) findings. More studies are still needed to clarify this condition.
7.2 Conclusions
Based on the main findings of this PhD research, it is concluded:
Chapter 2•  There are several in vitro biofilm models to study dental caries available in literature, however, only few studies showed dose-response and reproducibility validation.•  Multiplaque artificial mouth (MAM), microplate and flow chamber/ cell 
biofilm model approaches showed dose-response to anticaries or antimicrobial substances.•  Reproducibility of the dose-response pattern only was found for microcosm microplate model.
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Section 1 (Chapter 3 and 4)• The minimum gap size for secondary caries wall lesion development may be as small as 30 µm.• In gaps narrower than about 13 µm no secondary caries wall lesion formation could be observed.• No relationship between gap size threshold and caries activity level could be observed in situ.
Section 2 (Chapter 5 and 6)• 2% CHX used as MMP inhibitor on dentin pre-treatment during adhesive procedures did not slow down secondary caries wall lesion progression in the 
interface conditions tested in complex in vitro and in situ biofilm models.
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Chapter 8
8.1 SummaryT his PhD thesis is based on five studies that aimed to investigate the role of local factors in relation to the development of secondary caries lesions
Chapter 1 describes the etiology and histology of secondary caries reviewing 
the several factors that could inﬂuence the secondary caries process.
Chapter 2 presents a systematic review of in vitro biofilm models to study dental caries. This review addresses key methodological aspects of in vitro biofilm models for caries-related research, verifying their reproducibility and dose-response to anti-caries and/or antimicrobial substances. The review included models that 
produce a cariogenic biofilm and/or caries-like lesions with pH ﬂuctuations and 
models showing an eﬀect of anti-caries and/or antimicrobial substances. Basically 
the models consisted of dynamic or batch biofilm models varying in inoculum source and in carbohydrate exposure protocols. Dose-response validation was reported in 20.4% and reproducibility assessment in 14.3% of the studies. Almost a third 
(32.7%) of the models with dose-response validation were classified as high risk of bias. It was concluded that several in vitro biofilm caries models are available, but most of them lack validation by dose-response and reproducibility experiments.
Section 1 (Chapter 3 and 4) focuses on small gap sizes as a local factor in secondary caries lesion development.In Chapter 3 an in vitro study evaluated the development of dentin wall lesions 
in very small gaps next to resin composite using a biofilm model, and evaluated whether a relevant threshold for the gap size could be established. Samples were either restored with composite resin without adhesive procedure (no intentional gap; no bonding [NB] group) or with intentional gaps of 30, 60, or 90 µm, or with 
complete adhesive procedure (no gap; bonding [B] group). Microcosm biofilms were grown for 14 days within the small interfacial gaps under intermittent cariogenic challenge and secondary caries wall lesion progression was measured using Transversal Wavelength Independent Microradiography (T-WIM) at 3 locations: outer surface lesion and wall lesions at 200 and 500 µm distance from gap entrance. Results showed that the presence of an intentional gap (30, 60, and 90 µm) affected 
the secondary caries progression at 200 µm from the gap entrance (p ≤ 0.013). The 
NB group did not show significant wall lesion development (p ≥ 0.529). At 500 µm distance almost no wall caries development was observed. In conclusion, dentin wall lesions developed in very small gap sizes, and the threshold for secondary wall 
lesion development was a gap of less than 30 µm in this microcosm biofilm model.
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Chapter 4 investigated the influence of very small gaps between tooth and restoration in secondary caries (SC) development and additionally to link the level of SC and a threshold gap size with the caries activity level of the volunteer. 
For 21 days, 15 volunteers wore a modified occlusal splint loaded with dentin-composite samples restored according to different interface conditions: bonded (B = samples restored with complete adhesive procedure), no-bonded (NB = restored with composite resin without adhesive procedure), and 30, 60 and 90 µm (no adhesive procedure and with intentional gap). Eight times per day, the splint with samples was dipped in a 20% sucrose solution for 10 minutes. Before and after caries development, samples were imaged with T-WIM and lesion depth and mineral loss were calculated. Volunteers were grouped according to the average 
wall lesion depth and classified as high, mid and low caries activity levels. No wall lesion formation was observed in B and NB groups. In general, intentional gaps led to SC lesion depth progression independent of caries activity level of volunteers. No substantial wall lesions were found for two volunteers. A trend for deeper lesion in larger gaps was observed for the high activity group. In conclusion, very small gaps around or wider than 30 µm develop SC independent of the caries activity level of the patient and SC wall lesion progression seemed to be related to individual factors even in this standardized in situ model.
Section 2 (Chapter 5 and 6) is also composed by an in vitro and in situ studies 
and aimed to investigate the role of CHX, an MMP inhibitor, acting as local factor to prevent secondary caries lesion development.
Chapter 5 using an in vitro study investigated the role of MMP inhibitor (2% 
CHX) in secondary caries wall lesion development in different interface conditions in two runs (run 1 / small gaps = Bonded, no-bonded, 30, 60 or 90 µm and run 2 / wider gaps= bonded, no-bonded 100 µm and 100 µm+B). Dentin discs were 
restored and pre-treated with or without chlorhexidine 2%. Microcosm biofilms were grown on dentin-composite samples (14 days) and caries lesion outcomes were analysed by transversal wavelength independent microradiography (T-WIM) at three locations: outer surface and interface wall (200 and 500 µm distance from gap entrance). Linear regression analyses showed that pre-treatment with MMP 
inhibitor did not influence the wall lesion progression at either location (p ≥ 0.218). 
Interfaces with intentional gaps showed positive and significant effect on the wall 
lesion progression at 200 µm distance from the gap entrance (p ≤ 0.005). A small trend of increase in wall lesion development was observed at the 200 µm location when bonding was present on the composite side. In conclusion, the dentin pre-
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treatment with MMP inhibitor (CHX 2%) was not able to slow down the secondary 
caries wall lesion development in small and wide gaps in this biofilm model.
In Chapter 6, an in situ study aimed to investigate whether the dentin treatment 
with MMPs inhibitor (CHX 2%) could influence the development of secondary caries wall lesions in different dentin-composite interfaces. Similarly to Chapter 4, 15 
volunteers wore a modified-occlusal splint loaded with dentin-composite samples 
treated or not with CHX and restored according 4 different interface conditions: Bonding (B = samples restored with complete adhesive procedure), no bonding (NB = restored with composite resin without adhesive procedure), 100 µm (no adhesive procedure and with intentional gap) and 100 µm + B (adhesive material on composite side and intentional gap). Eight times per day, the splint with samples was dipped in a 20% sucrose solution for 10 minutes. Before and after caries development, samples were imaged with T-WIM and lesion depth (LD) and mineral loss (ML) were 
calculated. Results showed that dentin treatment with CHX did not significantly 
affect the caries lesion progression (LD and ML; p ≥ 0.261). Dentin wall lesions were observed in the 100 µm and 100 µm+B groups independently of MMP inhibitor treatment. In conclusion, the treatment of dentin with MMP inhibitor was not able to slow down the secondary caries wall lesion development in this in situ study.Finally, in Chapter 7 the available literature on secondary caries and study designs / gap size / caries risk / tooth-material interface / MMP inhibitor is discussed. The strengths and limitations of the different methodologies used in this thesis are also discussed.
8.2 ResumoE sta tese de doutorado está baseada em cinco estudos que objetivaram investigar o papel de fatores locais associados ao desenvolvimento de lesões de cárie secundária (limiar para o gap interfacial / limiar para o gap interfacial e risco de 
cárie / inibidor de MMP) e adicionalmente mostrar uma visão geral sobre modelos 
de biofilmes in vitro para o estudo da cárie dentária.O capítulo 1 descreve a etiologia e a histologia das lesões de cárie secundária 
perfazendo uma visão geral sobre diversos fatores que poderiam influenciar no desenvolvimento da cárie secundária.O capítulo 2 apresenta uma revisão sistemática de literatura sobre modelos 
de biofilme in vitro para o estudo da cárie dentária. Essa revisão objetivou 
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caracterizar e discutir os aspectos metodológicos chaves de modelos de biofilme 
in vitro relacionados a pesquisa de cárie dentária e verificar a reprodutibilidade e dose-resposta desses modelos considerando a resposta para agentes anti-cárie e 
substâncias antimicrobianas. Nessa revisão foram incluídos modelos de biofilme 
que gerassem biofilme cariogênico e / ou lesões artificiais de cárie com flutuações 
de pH e que mostrassem o efeito de substancias anti-cárie e / ou antimicrobianas. Basicamente, os modelos consistiram de modelos dinâmicos e estáticos variando 
em relação a fonte de inóculo e a protocolos de exposição a carboidratos. 
Respectivamente, 20,4 e 14,3% dos estudos reportaram validações dose-responsta 
e reprodutibilidade. Quase um terço (32,7%) dos modelos com validações dose-
resposta foram classificados como alto risco de viés. Apesar de diversos modelos 
de biofilme in vitro estarem disponíveis na literatura para pesquisas relacionadas 
a cárie dentária, a maioria deles ainda carecem de validações dose-resposta e experimentos de reprodutibilidade para cada protocolo proposto.A sessão 1 (capítulos 3 e 4) tem como foco a avaliação da presença de pequenos tamanho de gaps como fatores locais no desenvolvimento da cárie secundária.No capítulo 3 um estudo in vitro usando um modelo de biofilme avaliou o desenvolvimento de lesões de parede próximas a resina composta contendo 
gaps muito pequenos. Além disso, avaliou se um limiar relevante de tamanho de gap poderia ser estabelecido. O fator em estudo foi o tamanho do gap: amostras foram ou restauradas com resina composta sem procedimento adesivo (sem gap 
intentional; grupo sem adesão [NB]) ou com gaps intentionais de 30, 60, or 90 μm, 
ou com procedimento adesivo completo (sem gap, adesão perfeita [B]). Biofilme de microcosmos foram crescidos por 14 dias dentro de gaps interfaciais entre discos de 
resina composta-dentina sobre um regime intermitente de desafio cariogênico. As 
lesões de cárie secundárias de parede foram mensuradas usando microrradiografia 
de onda tranversal independente em 3 localizações: na lesão superficial e na lesão 
de parede em 200 e 500 μm da entrada do gap. Os resultados mostraram que a 
presença de gaps intencionais (30, 60, and 90 μm) afetaram a progressão de cárie 
secundária em 200 μm a partir da entrada do gap (p ≤ 0.013). O grupo NB não 
mostrou significantimente desenvolver lesões de parede (p ≥ 0.529). Em 500 μm da 
entrada do gap lesões de parede não foram praticamente observadas. Em conclusão, lesões de parede em dentina se desenvolveram em tamanhos muito pequenos de gaps e o limiar para o desenvolvimento de cárie secundária de parede foi de um gap 
de tamanho de aproximadamente 30 μm, considerando o modelo de microcosmos.
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O capítulo 4 investigou in situ a influência de gaps muito pequenos entre 
dente e restauração no desenvolvimento de cárie secundária e adicionalmente 
correlacionou o nível de cárie secundária com o limiar de tamanho de gap com o 
nível de atividade de cárie do voluntário. Por 21 dias, 15 voluntários usaram um 
dispositivo oclusal modificado com amostras de dentina restauradas de acordo com 
diferentes condições de interfaces: aderida (B = amostras foram restauradas com 
resina composta e procedimento adesivo completo), sem adesão (NB = amostras foram restauradas com resina composta sem procedimento adesivo), e 30, 60 e 90 µm (sem procedimento adesivo e com gaps intencionais). Oito vezes por dia, 
o dispositivo oclusal foi imerso em solução de sacarose a 20% por 10 minutos. Antes e depois do desenvolvimento das lesões de cárie, imagens das amostras 
foram realizadas através de T-WIM e a profundidade de lesão e a perda mineral 
foram calculadas. Os voluntários foram agrupados de acordo com a média de 
profundidade das lesões de parede e classificados em níveis de atividade de cárie 
alta, média e baixa. Lesões de cárie de parede não foram formadas nos grupos B e 
NB. De forma geral, a presença de gaps intencionais levaram a progressão das lesões 
independente do nível de atividade de cárie do voluntário. Não foram observadas 
lesões consideráveis em dois voluntários. Uma tendência para lesões de parede 
mais profundas em gaps mais largos foi observada para os indivíduos classificados 
como alto nível de atividade de cárie. Em conclusão, gaps muito pequenos em torno 
ou maiores de 30 µm desenvolveram cárie secundária independentemente do nível 
de atividade de cárie do voluntário e a progressão das lesões de parede pareceu estar relacionada a fatores individuais mesmo em um modelo in situ padronizado.
A sessão 2 (capítulos 5 e 6) é também constituída por estudos in vitro e in situ, e 
objetivou investigar o papel da clorexidina (CHX), um inibidor de metaloproteinases da matrix (MMP), atuando como um fator local para o desenvolvimento de cárie secundária.
No capítulo 5 um estudo in vitro investigou o papel de um inibidor de MMP 
(2% CHX) no desenvolvimento das lesões de cárie secundária de parede frente a 
diferentes condições de interfaces em duas rodadas ( rodada 1 / pequenos gaps = 
adesão, sem adesão, 30, 60, 90 µm e rodada 2 / gaps amplos = adesão, sem adesão, 100 µm e 100 µm+adesivo no lado da resina composta). Os discos de dentina foram 
restaurados e pré-tratados com e sem CHX 2%. Biofilme de microcosmos foram crescidos sobre as amostras de dentina-resina composta (14 dias) e os desfechos 
de cárie dentária foram analizados por microrradiografias de onda transversal 
independente (T-WIM) em 3 localizações: lesão superficial e na lesão de parede (em 
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200 e 500 µm da entrada do gap). Análises de regressões lineares mostram que o 
pré-tratamento com inibidor de MMP não influenciou a progressão das lesões de 
parede em qualquer localização (p ≥ 0.218). As interfaces com gaps intencionais 
mostraram um efeito positivo e significante na progressão das lesões a partir de 
200 µm da entrada do gap (p ≤ 0.005). Uma pequena tendência para o aumento das lesões de parede foi observado em 200 µm da entrada do gap quando o adesivo 
estava presente no lado da resina composta. Conclui-se que o pré-tratamento da 
dentina com inibidor de MMP (CHX 2%) não foi capaz de diminuir o desenvolvimento das lesões de cárie secundária de parede em gaps pequenos e amplos utilizando 
esse modelo de biofilme.O capítulo 6, objetivou investigar in situ se o tratamento da dentina com 
inibidor de MMP (CHX 2%) poderia influenciar o desenvolvimento de lesões de cárie secundária de parede em diferentes interfaces de dentina-resina composta. 
De forma similar ao capítulo 5, 15 voluntários usaram um dispositivo oclusal 
modificado contendo amostras de dentina-resina composta tratadas ou não com 
CHX e restauradas de acordo com quatro diferentes condições de interface: adesão 
( B = amostras restauradas com procedimento adesivo completo), sem adesão ( NB = amostras restauradas com resina composta e sem procedimento adesivo), 100 µm ( sem procedimenro adesivo e com gap intencional) e 100 µm + B (adesivo localizado ao lado da resina composta). Antes e depois do desenvolvimento das lesões, imagens das amostras foram realizadas com T-WIM e a profundidade de 
lesão (PL) e perda mineral (PM) foram calculadas. Os resultados mostraram que 
o tratamento da dentina com CHX não afetou significantemente a progressão das 
lesões de cárie (PL e PM; p ≥ 0.261). Lesões na parede de dentina foram observadas nos grupos 100 µm and 100 µm+B independentemente do tratamento com inibidor 
de MMP. Conclui-se que o tratamento com MMP inhibitor não foi capaz de diminuir o desenvolvimento das lesões de parede no estudo in situ.Finalmente, no capítulo 7, a literatura disponível sobre cárie secundária e design de estudos / tamanho de gaps / risco de cárie / interface dente-material / inibidor 
de MMP foi discutida. Além disso, os pontos fortes e as limitações das diferentes 
metodologias usadas nessa tese também foram comentadas.
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8.3 SamenvattingD it proefschrift is samengesteld uit vijf studies die als doel hadden de rol van lokale factoren in het ontstaan van secundaire cariëslaesies te onderzoeken.
Hoofdstuk 1 beschrijft de etiologische factoren en histologische processen die ten grondslag liggen aan het ontstaan van secundaire cariëslaesies.
Hoofdstuk 2 beschrijft een systematisch literatuuroverzicht van biofilm modellen die worden gebruikt om secundaire cariës in vitro na te bootsen. De centrale 
methodologische aspecten van biofilm modellen die in vitro worden toegepast voor cariësgerelateerd onderzoek worden hierin vergeleken. De reproduceerbaarheid en dosis-respons validatie van anticariogene of antimicrobiële stoffen worden 
geverifieerd. Modellen die een cariogene biofilm en/of op cariës gelijkende laesies 
produceerden door middel van pH schommelingen werden geïncludeerd, evenals modellen die het effect van een cariostatisch of antimicrobieel middel onderzochten. 
In feite bestonden de modellen uit dynamische of constante biofilm simulaties met verschillende entmaterialen en protocollen voor blootstelling aan koolhydraten. Dosis-respons validatie werd in 20,4% van de gevallen gerapporteerd en een inschatting van de reproduceerbaarheid werd in 14,3% van de studies gemaakt. Bijna een derde (32,7%) van de studies die een dosis-respons validatie toepasten had een hoog risico op vertekening (bias). Concluderend: er zijn verschillende in 
vitro biofilm modellen beschikbaar voor cariësonderzoek, maar de meesten missen adequate validatie in de vorm van een test op dosis-respons of reproduceerbaarheid.
Sectie 1 (Hoofdstukken 3 en 4) richt zich op smalle randspleten als een lokale factor in het ontstaan van secundaire cariëslaesies.In Hoofdstuk 3 werd door middel van een in vitro studie het ontstaan van wandlaesies in dentine in zeer smalle randspleten naast composietrestauraties 
geëvalueerd, gebruikmakend van een biofilm model. Een belangrijke vraag hierbij was of er een relevante drempelwaarde voor de grootte van de randspleet kon worden vastgesteld. Proefstukjes werden gerestaureerd met composiet zonder adhesieve middelen (geen intentionele randspleet; geen bonding [NB] groep), met een intentionele randspleet van 30, 60 of 90 µm, of met een complete 
adhesieve procedure (geen randspleet; bonding [B] groep). Microkosmos biofilms werden gedurende 14 dagen gekweekt in de kleine randspleten terwijl deze werden blootgesteld aan periodieke cariogene omstandigheden. Secundaire cariësprogressie van de wandlaesies werd gemeten door gebruik te maken van 
T-WIM (transversale, golflengteonafhankelijke microradiografie) op drie locaties: 
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oppervlaktelaesies, wandlaesies op 200 µm van de ingang van de randspleet en wandlaesies op 500 µm van de ingang van de randspleet. De resultaten lieten zien dat de aanwezigheid van een intentionele randspleet (30, 60 of 90 µm) het ontstaan van secundaire cariëslaesies op 200 µm afstand van de ingang van de randspleet 
beïnvloedde (p ≤ 0,013). De NB groep liet geen significante laesieontwikkeling zien 
(p ≥ 0,529). Op 500 µm afstand van het oppervlak werd nauwelijks ontwikkeling van wandlaesies waargenomen. Dit leidt tot de conclusie dat wandlaesies zich in dentine naast erg smalle randspleten kunnen ontwikkelen, en dat de drempelwaarde van de randspleet voor het ontstaan van secundaire wandlaesies in dit microkosmos 
biofilm model niet meer dan 30 µm bedroeg.
Hoofdstuk 4 bestudeerde de invloed van zeer smalle randspleten op secundaire cariësontwikkeling in een in situ model, en probeerde verder de drempelwaarde voor de ontwikkeling van secundaire wandlaesies naast composietrestauraties te relateren aan de hoeveelheid cariësactiviteit van de proefpersonen. Gedurende 
21 dagen droegen 15 vrijwilligers een gemodificeerde occlusale opbeetplaat die proefstukjes van dentine gerestaureerd met composiet bevatten. De proefstukjes waren gerestaureerd volgens verschillende condities: met composiet zonder adhesieve middelen (geen intentionele randspleet; geen bonding [NB] groep), met een intentionele randspleet van 30, 60 of 90 µm, of met een complete adhesieve procedure (geen randspleet; bonding [B] groep). De vrijwilligers doopten de opbeetplaat die de samples bevatte 8 keer per dag 10 minuten lang in een oplossing van 20% sucrose. Voor en na deze drie weken durende cariogene omstandigheden werden de proefstukjes gefotografeerd met behulp van de T-WIM methode. Laesiediepte en mineraalverlies werden berekend. De vrijwilligers werden in 
verschillende groepen ingedeeld afhankelijk van de gemiddelde laesiediepte van de wandlaesies. In de B en NB groepen werden bij geen enkele vrijwilliger wandlaesies waargenomen. Over het algemeen werden bij de intentionele randspleten 
wandlaesies waargenomen, onafhankelijk van het niveau van cariësactiviteit bij de vrijwilligers. Bij twee vrijwilligers werden helemaal geen substantiële wandlaesies gemeten. Er was een trend zichtbaar van diepere laesies in grotere randspleten in de groep met een hoog niveau van cariësactiviteit. Duidelijk is dat zich in erg smalle 
randspleten van ten minste 30 µm wandlaesies lijken te ontwikkelen, onafhankelijk van de hoeveelheid cariësactiviteit van de patiënt. Verder leek de progressie van wandlaesies ook in dit gestandaardiseerde in situ model gerelateerd te zijn aan individuele factoren.
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Sectie 2 (Hoofdstukken 5 en 6) beschrijft ook een in vitro en een in situ studie. 
Deze richtten zich op het vermogen van chloorhexidine (CHX), een matrix metallo 
proteïnase (MMP) remmer, om lokaal de ontwikkeling van secundaire cariëslaesies te voorkomen.In Hoofdstuk 5 werd de invloed van een MMP remmer (2% CHX) op de ontwikkeling van secundaire wandlaesies bestudeerd in verschillende interface condities in twee rondes (Ronde 1 / smalle randspleten: bonding, geen bonding, 30, 60 en 90 µm randspleten. Ronde 2 / bredere randspleten: bonding, geen bonding, 
100 µm randspleten en 100 µm randspleten met bonding). Dentine schijfjes werden 
al of niet behandeld met een 2% CHX oplossing en gerestaureerd met composiet. 
Microkosmos biofilms werden gekweekt op de proefstukjes (gedurende 14 dagen) en laesiediepte en mineraalverlies werden geanalyseerd met T-WIM op drie locaties: op het oppervlak, in de randspleet op 200 µm van de ingang van de randspleet en in de randspleet op 500 µm van de ingang van de randspleet. Lineaire regressie analyse liet geen invloed zien van de behandeling met een MMP remmer op de ontwikkeling 
van wandlaesies op een van beide wandlocaties (p ≥ 0,218). De aanwezigheid van 
een randspleet in het proefstukje had een positief significant effect op het ontstaan 
van wandlaesies op 200 µm afstand van de ingang van de randspleet (p≤0,005). Een lichte neiging tot grotere wandlaesies werd waargenomen in de samples waarin bonding aanwezig was op het composiet. Behandeling van het dentine met een MMP 
remmer (2% CHX) leek de formatie van secundaire cariëslaesies in dit biofilm model in grote noch kleine randspleten te vertragen.In Hoofdstuk 6 werd een studie beschreven waarin door middel van een in situ model nogmaals het effect van behandeling van dentine met een MMP remmer (2% 
CHX) op het ontstaan van wandlaesies in dentine naast composiet is onderzocht. Vergelijkbaar met de studie in hoofdstuk 4 werd 15 vrijwilligers gevraagd om een 
gemodificeerde occlusale opbeetplaat te dragen waarin proefstukjes van dentine en composiet waren gemonteerd. De proefstukjes waren in vier groepen ingedeeld: bonding (B = proefstukjes gerestaureerd met een volledige adhesieve procedure), geen bonding (NB = gerestaureerd met composiet zonder adhesieve procedure), 100 µm (geen adhesieve procedure en met intentionele randspleet) en 100 µm + B (adhesief bonding materiaal aangebracht op composiet zijde, met intentionele randspleet van 100 µm). De vrijwilligers doopten de opbeetplaat met de proefstukjes acht keer per dag in een 20% sucrose oplossing gedurende tien minuten. De proefstukjes werden voor en na blootstelling aan het mondmilieu gefotografeerd met behulp van T-WIM. Laesiediepte (LD) en mineraalverlies (ML) werden berekend. 
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Uit de resultaten bleek dat behandeling van het dentine met CHX de progressie 
van wandlaesies niet significant beïnvloedde (uit zowel LD als ML; p ≥ 0.261). In 
de groepen 100 µm en 100 µm + B werden, onafhankelijk van de behandeling met MMP remmer, wandlaesies in het dentine waargenomen. Concluderend liet deze studie geen effect zien van behandeling met een MMP remmer op de ontwikkeling van secundaire wandlaesies.Tot slot bevat Hoofdstuk 7 een geïntegreerde discussie van de resultaten.
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